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 I 
Abstract	  
This paper examines the potential application of trademarks as a complemen-
tary indicator of innovation. Recent innovation literature finds a correlation be-
tween innovation and usage pattern of trademarks. Especially for the service 
industry this new approach offers potential since R&D and patents indicators 
do not capture innovation in these sectors. To understand the relationships 
between trademarks and innovation the German pharmaceutical and IT-
service industries were studied. As a proxy for innovation sales and employ-
ment growth were introduced. The impact of filing a trademark was then com-
pared with a control group and correlations with patents examined. The re-
sults show that trademarks indeed can be used as an indicator of innovation; 
however, with some limitations. While IT-service companies show a strong 
relationship between trademarks and growth, the results for the pharmaceuti-
cal industry are ambiguous and need to be further examined.  
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1. Introduction  
The understanding that innovation is an essential driver of economic growth is 
established in today’s society. As Schumpeter (1939, p. 83) states “nothing 
can be more plain or even more trite common sense than the proposition that 
innovation is at the center of practically all the phenomena, difficulties, and 
problems of economic life in capitalist society”. The importance of innovation 
is illustrated by various rankings like Forbes’ world’s most innovative compa-
nies ranking, the Global Innovation Index or Bloomberg’s innovation index, 
which rank companies or countries by its degree of innovation. However, the 
measurement of innovation is still an ongoing discussion in the scientific 
community. Many different approaches have been developed and today R&D 
expenses, number of patents or patents citations are frequently used to de-
termine the level of innovation in companies. A relatively new method is the 
application of trademarks as an indicator of innovation. The purpose of this 
paper is to determine the usefulness of trademarks to measure innovation 
based on empirical evidence from the German pharmaceutical and IT-service 
industry.  
7 million trademarks applications have been filled in 2013, making them the 
most used form of intellectual property, even before patents with 2,6 million 
applications (WIPO, 2014). The enormous number demonstrates the signifi-
cance as a tool for companies and the application of trademarks as an indica-
tor of innovation is a logical consequence. The usage of trademarks offers two 
improvements over the current indicators. Firstly, trademarks are part of the 
effort of companies to make money with their products, services and inven-
tions. While R&D can be viewed as an input into the innovation process and 
patents represent the output, none of these two indicators establish the con-
nection between innovation and commercialization. Trademarks can help to 
overcome this gap since they are a crucial part of companies marketing activi-
ties (Krasnikov, Mishra and Orozco, 2009). Secondly, service industries are 
adversely affected by R&D and patent indicators because such intellectual 
property rights (IPR) are hardly used within these sectors. Hence, new indica-
tors have to be developed in order to determine innovation for service compa-
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nies. Trademarks seem to be a promising approach since they are equally 
used within all kind of industries.  
In order to understand the usability of trademarks as a commentary indicator 
of innovation, this paper developed a new approach. While many studies tried 
to examine the usefulness by calculating correlation between trademark and 
patents or conducting surveys, none uses trademarks to measure the impact 
of innovation. This study attempts to overcome this gap by linking trademarks 
to growth statistics, which represents the outcome of successful innovation. 
Chapter 2 discusses the theoretical and empirical literature of trademarks and 
innovation. The legal background is outlined and relevant processes in order 
to obtain a trademark are explained. The legal part is followed by an overview 
of the current state of research about innovation indicators. Additionally, the 
bridge is build between innovation and growth statistics. Chapter 3 covers the 
empirical part of this paper. The data sources and specification are presented 
and the applied methodology of the empirical work explained. The second 
part of chapter 4 is split into descriptive and growth analyses and discusses 
the results obtained by the empirical analyses. This cover sales as well as 
employment growth. Chapter 5 concludes the paper, summarizes the empiri-
cal findings and discusses potential application of trademarks as a commen-
tary indicator of innovation.  
2. Theoretical and Empirical Discussion of Trade-
marks and other indicators of innovation 
In order to examine the usefulness of marks as an indicator of innovation, one 
has to firstly understand the original purpose of trademarks, its evolution as 
well as today’s legal background and the rights, which are granted.  
2. 1 Trademark as an intellectual property right 
The first evidences of marks are found 5.000 BC as an identifier for the own-
ership of livestock. Over the centuries the purpose evolved and during the 
Roman Empire a bricks bored the marks of its manufacturer in order to serve 
as a designation of the producer and his obligation for quality. With the advent 
of industrialization trademarks became more relevant for the economy and 
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hence a number of explicit trademark laws were issued in France (1857), the 
United Kingdom (1862), the United States (1870) (Mendonça, Pereira and 
Godinho, 2004). According to the Supreme Court of the United States in 1871 
the purpose of a trademark “is to identify the origin or ownership of the goods 
to which it is affixed” and that this origin or ownership must be of a personal 
nature (Schechter, 1927, p. 814).  
In today’s economy, however, the origin rarely plays a role in consumer deci-
sions. The World Intellectual Property Organization (WIPO) defines a trade-
mark as a “distinctive sign, which identifies certain goods or services as those 
provided by a specific person or enterprise” (WIPO, 2004, p. 8). The definition 
implies two essential objectives of trademarks, namely protection and dissem-
ination. These two indistinguishable functions of trademarks grant company 
exclusive rights to mark its products and at the same time prohibit other par-
ties to use the same trademark. Combining the functions allows customers to 
use trademarks as an identifier for customers to assign a level of satisfaction 
to a certain product and stimulate future purchases (Schechter, 1927). Hence, 
trademarks can be regarded as a marketing assets and are highly intertwined 
with brands (Aaker, 1991). This connection infers that “firms’ trademark activi-
ties capture a significant portion of their branding efforts” (Krasnikov, Mishra, 
and Orozco, 2009, p. 154). However, brands are not identical in value and the 
determination of this value depends on many factors. In management litera-
ture different sets are used, such as name awareness, customer loyalty, per-
ceived quality and associations with the brand, that add value to the product 
being offered (Aaker, 1991). Economides is one of the first to examine the 
‘Economics of trademarks’ and draws one important conclusion: a trademark 
should be filled when its expected revenues its the discounted costs. This 
means that companies only use brands if they expect a differentiation in the 
market from it and to extract returns (Economides, 1988). 
From simple identifier of origin to complex indicators of satisfaction and reve-
nue extraction tools, the evolution of trademarks demonstrates two important 
facts: 1) successful trademarks can be a highly valuable form of property of 
companies, even though they are intellectual respectively intangible assets of 
an organisation, 2) trademarks help to distinguish products from the ones of 
competitors and hence help providing an economical niche for organisations 
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in competition (Hunt, Muncy and Ray, 1981). These features make trade-
marks an important tool of competition and assign them a key role in today’s 
economy. Examining the usage of trademarks offers insights into the market-
ing activities and the willingness to protect its products. In contrast, patents 
transfer information about the technical knowledge of a company (Sandner 
and Block, 2011). The next part will explain the legal background of trade-
marks and the criteria to obtain one. Furthermore, differences compared to 
patents will be outlined.  
2.1.1 Trademark Law  
In the application process, certain legal requirements are checked and an ex-
amination of the aspired trademark takes place. Three main requirements 
have to be fulfilled in order to successfully register a trademark (European 
Council, 1993). The first and most important requirement is distinctiveness. 
Since the main purpose of a trademark is to identify products and its quality, a 
new trademark should not deceive or mislead customers. Similarity and con-
flict with other trademarks are hence forbidden. Secondly, a trademark should 
be able to graphically represent a company, respectively brand. Today vari-
ous kinds of trademarks are allowed. The most used ones are word and fig-
urative trademarks, but also sounds, colours, fragrances and 3D forms can be 
registered. Thirdly, a generic sign or word cannot be registered since the pur-
pose of a trademark is to establish a direct link between a company and cus-
tomers (WIPO, 2012).  
The criteria for registering a trademark are in sharp contrast to criteria for pa-
tents. Patents are only granted to technical ideas on the basis of non-
obviousness, inventiveness in the face of prior art and the potential for indus-
trial application Besides the difference in the purpose, there are several other 
important legal requirements Firstly, the length of the period during which the 
exclusive rights are granted. While a patent normally expires after 20 years, a 
trademark can be renewed indefinitely. This renewal however, requires a reg-
ular fee and therefore makes it costly for companies to maintain a trademark 
(WIPO, 2004a). Furthermore, the law requires trademarks to be used and 
non-usage leads can lead to the cancelation of a trademark after a period of 
usually five years within the European Union (OHIM, 2014). Millot (2009) finds 
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evidence that many trademarks are actually not use and cancelled after a pe-
riod of six or seven years.  
The time between filing and finally obtaining a trademark it is much smaller 
compared to patents. Successfully registering a trademark in Europe normally 
takes up to one year. In contrast the process for a patent can last as long as 
five years. Moreover, the usage of a trademark is not linked to the filings. 
Companies can use trademarks before or directly after the filing and the regis-
tration is a requirement only for protection against the usage of others (WIPO, 
2004a). 
The first international trademark agreement was reached at the Paris conven-
tion 1883. Its main outcome was that foreign applicants enjoy the same rights 
as local holders. Today the WIPO, which emerged from this conference, facili-
tates Intellectual property rights on the global scale. In the Europe Union the 
Office for Harmonization in the Internal Market (OHIM) was established in 
1994 and with it the Community Trademark (CTM), which allows simultaneous 
registering of trademarks in all European countries and provides a relevant 
and complete database (Mendonça, Pereira, and Godinho, 2004).  
The next chapter demonstrates how brands and trademarks interlink with the 
theory of innovation and how they might be used to measure innovation in or-
ganisations.  
2.2 Indicators of Innovation at the Company Level 
The key players in the innovation process are business enterprises. Their 
combination of short-term abilities and long-term vision make them the main 
driver of technological change (Chandler, 1994). The innovation process is 
defined as a learning process that generates or acquires new knowledge with 
the ultimate goal to utilise this knowledge and create an economic value (Witt, 
1993). It can be split into two parts: economic creativity and innovation imple-
mentation (Williams and McGuire, 2010). Economic creativity is ‘‘any form of 
creativity that results in codified knowledge with potential economic value’’. 
However, Innovation ‘‘goes beyond’’ creativity and implementation is a central 
part of it. Only put together innovation occurs and each part requires different 
measures and indicators (Guerrero-Cusumano and McGuire, 2001). 
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The measurement of innovation activities in companies is highly complex and 
to pinpoint effects and relevance is a difficult undertaking, which is aggravated 
by economic, social, technological and organisational interdependences 
(OECD, 1992). In order to be a suitable indicator several requirements have 
to be fulfilled: 1) a significant correlation between the indicator and innovation 
has to exist 2) the number of applications has to be sufficiently high in order to 
achieve statistically relevant results 3) the indicators has to be electronic ac-
cessible 4) a partition along various factors is crucial 5) An international com-
parison should be possible (Schmoch, 2003). Until this point various indica-
tors have been developed and used to measure innovation on a firm level.  
Like the innovation process itself, its indicators can be divided into the two 
groups: economic creativity and innovation implementation. Economic creativ-
ity can be further divided into input and output driven indicators. R&D expendi-
tures are mainly used to measure innovation input, while output and its quality 
is measured through the number of patents, respectively the number of cita-
tions a patent receives. R&D is understood as an investment activity of com-
panies into its ‘knowledge stock’ and can thus be used as a proxy to under-
stand how much companies invest into its innovation capabilities (Hall, Jaffe, 
and Trajtenberg, 2005).  
Patents are the output of the R&D activity of companies. Pakes and Griliches 
(1980) were able to prove this strong relationship between R&D and patents.  
Across various firms and industries they demonstrate a company can change 
its inventive output (patents) by adjusting the input (R&D). As a first approach 
on a macro scale, the number of patents per company has been used as an 
indicator (Griliches, 1984; Scherer, 1965; Schmookler, 1666). Using only the 
number of patents, however, is inherently limited since patents vary extremely 
in their value and technological importance and hence, further indicators were 
developed. A first step towards understanding the heterogeneity of patents 
was the examination of renewal rates by Pakes and Schankerman (1984), 
which demonstrated obvious differences in patents. In order to determine the 
importance of patens, citations were revealed as the obvious mean to achieve 
this goal. Trajtenberg (1990) and Albert, Avery, Narin and McAllister (1991) 
were the first among other to follow this new path to classify patents and thus 
derive better results and more meaningfulness from patent data. The citation 
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approach conveys two major implications of innovation. Firstly, citations allow 
to link inventions and its distribution over the world and influence on new in-
ventions. Secondly, it allows assigning ‘values’ to patents and thereby differ-
entiating between patents and its importance (Hall, Jaffe and Trajtenberg, 
2005).  
Even though R&D remains the stronger indicator for market values, several 
studies examined the usage of citations as a determinant of the market value. 
While (Hall, 2000) finds that the explanatory power is lower compared to R&D 
expenses, patents still add useful information above and beyond R&D. Hall, 
Jaffe and Trajtenberg (2005) demonstrate that patent citations can be used as 
a complementary indicator besides R&D. Citations are more correlated to 
R&D than simple patent counts and including them into market value equa-
tions increases the predictive power of a Tobin’s q analysis. 
While R&D and patents respectively patent citations provide interesting in-
sights about invention in companies and their technical level, its explanatory 
potential is limited. Both do not offer insights into commercial aspects of inno-
vation and it is thus questionable if all relevant areas are covered. Looking at 
Williams and McGuire (2010) definition of the two folded innovation process, 
only economic creativity is taken into account and innovation implementation 
left untouched by R&D and patent indicators. Overall, there is no single indi-
cator which can fully reflect innovative activity and its results (Malmberg, 
2005). 
Hence, further proxies have to be developed and combined with the existing 
ones in order to tackle shortcomings. A new promising approach is to use reg-
istered trademarks. Trademarks in particular are an indicator of innovation 
implementation (Williams and McGuire, 2010) and the next part discusses 
previous studies and the usefulness of trademarks from a theoretical point of 
view in order to measure innovation. 
2.3 Trademarks in Innovation Research 
Examining the current innovation research, theoretical as well as empirical 
justification for the usage of trademarks as an indicator can be found. Surveys 
across various industries have found that companies use different means to 
protect their innovations and extract returns. A common finding of all the stud-
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ies is that only in a few industries patents are used as the major tool to protect 
innovation only. Other tools such as secrecy, lead time or exploitation of repu-
tation are used and especially marketing activities and assets play a signifi-
cant role and are widely spread along various industries (Cohen, Nelson, and 
Walsh, 2000; Levin. Klevorick,Nelson and Winter, 1987). The importance of 
marketing, and hence trademarks, is confirmed when examining the associat-
ed costs of launching an innovation. Pavitt (1985) concludes that half of the 
expenditures are linked to R&D activities and the other half to production, en-
gineering and marketing.  
While not every trademark is linked to a new or innovative product or service 
Mendonça, Pereira and Godinho (2004) are able to connect innovations stud-
ies and trademarks using an economic rational. They argue that trademarks 
need to have an expected positive net present value in order to be filled. Only 
if the new product offers a substantial differentiation, a trademark is filled be-
cause sufficient profits can be generated. Hence, trademarks connected to an 
innovation represent the majority of filings. Furthermore, Mendonça, Pereira 
and Godinho conclude that trademarks are registered only shortly before the 
launch of a product, indicating a later phase in the innovation process com-
pared to patents.  
Following the arguments of Mendonça, Pereira and Godinho (2004) trade-
marks help understanding the last step in the innovation process, namely the 
innovation implementation, due to its connection to marketing efforts of com-
panies (Hipp and Grupp, 2005). Companies launching new innovations, asso-
ciate it to a new brand and apply for a new trademark to foster the perception 
by consumers (Millot, 2009). Therefore, it seams reasonable that companies 
only apply for new trademarks, when they launch major upgrades to inform 
the customers and not for minor enhancements (Malmberg, 2005).  Combin-
ing the arguments above, one can conclude that the registration of a trade-
mark indicates an innovation new to the firm, either in form of a major upgrade 
or as a new product or service.  
Considering practical arguments, there are several advantage using trade-
mark data as an indicator. Firstly, the available data is beneficial since trade-
marks have been recorded regularly and systematically for decades in many 
countries. Secondly, they fulfil all requirements for a statistical indicator: high 
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number available, electronically accessible, divided by sector and widely 
spread all over the world, enabling international as well as cross-industry 
comparison (Millot, 2009). 
2.3.1 Empirical Studies of Trademark Innovation 
There are also several empirical studies examining the connection between 
innovation and trademarks. (Allegrezza and Guard-Rauchs, 1999) examine 
the connection between innovation, proxied by R&D intensity, and trademarks 
of 2.500 Benelux SMEs. They are able to prove a significant positive relation. 
Schmoch (2003) finds similar results for the European manufacturing sector, 
namely a strong correlation between the usage of trademarks and patents. 
Results from the third Community Innovation Survey (CIS) delivers further ev-
idence regarding the usage of trademarks and patents by innovative firms. 
Across various European countries, the survey rates companies along their 
innovativeness and ask about the usage of IPRs. In general, the usage of 
trademarks is more widely spread than patents, which is logical due to the 
stricter legal requirements. Moreover, the survey demonstrates that innovative 
firms use more trademarks and patents than in non-innovative firms (Lucking, 
2004). These results are confirmed by Mendonça, Pereira and Godinho 
(2004) in their study about IPRs and in particular trademark usage. The evi-
dences from Portugal also suggest that companies, which use one form of 
IPR, also tend to use other IPRs.   
An exploration of the Swedish electromechanical, automotive and pharmaceu-
tical industries between 1945 and 1996 delivers ambiguous results. One the 
one hand trademarks are unreliable as an indicator in the automotive and 
electromechanical industry due to the inconsistent usage. Companies often 
use model numbers instead of trademarks to identify products and hence limit 
the explanatory power of trademarks. Swedish pharmaceutical companies on 
the other hand have been a frequent user of trademark for a long time. Firstly, 
a high percentage of new products have been trademarked. Secondly, the 
number of new trademarks has a significant long-term correlation with the fil-
ing of new drugs. Furthermore, a correlation between patents and trademarks 
in discovered; however, patents follow a 20-year peak interval while trade-
marks follow a 10-year peak interval. This lead to the conclusion that the 
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combination delivers interesting results regarding innovations studies and that 
trademarks are able to more short-term insight beyond the insights gained 
from patents (Malmberg, 2005).  
Only few studies examined the relationship between trademarks and econom-
ic performance of companies; however, these ones were able to find a posi-
tive a correlation. Griffiths, Jensen and Webster (2011) use trademark depos-
its, patents and industrial designs as an indicator of innovation and examine 
the influence on the growth of profits. They conclude that trademarks have a 
positive impact; however, not as strong as the one of patents and designs. 
Greenhalgh and Rogers (2012) find a similar relationship between trademark 
and a company’s stock value. It can be inferred that trademarks act as a 
proxy for unobservable characteristics that raise productivity. Seethamraju 
(2003) finds a positive correlation between trademarks and sales and are able 
to link the correlation to increased market values of companies. Krasnikov, 
Mishra, and Orozco (2009) evaluate the impact of trademark filings on the fi-
nancial performance of companies. Distinguishing between brand-
identification and brand-association trademarks, they find a positive relation 
between the filing of a brand-association trademark and a firm’s stability and 
size of cash flows, Tobin’s q, ROA and stock returns. However, the affect of 
filings diminishes with increasing customer brand awareness.  
2.3.2 Trademarks in the Service Industry  
Trademarks as an indicator of innovation are in the service industry are em-
phasised for two reasons: Firstly, the importance of the service sector for the 
economy has constantly risen over the last decades (Arundel, Kanerva, 
Cruysen and Hollanders, 2007; OECD, 2005) and examining innovation in the 
tertiary sectors becomes increasingly important. Secondly, the definition of 
appropriate innovation indicators for services is difficult (Djellal and Gallouj, 
1999)and patent and especially R&D measures have proven to be especially 
disadvantageous for the service industry (Hipp and Grupp, 2005). Hence, the 
development of new indicators is essential. 
Various studies examine the potential usage of trademarks as indicator in the 
service industries and provide interesting results. A study by Hipp and Grupp 
(2005) confirms that innovation in services is different to innovation in other 
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areas and hence, must be handled in a different way. A special emphasis is 
put on knowledge-intensive business services (KIBS), because these compa-
nies facilitate innovations in other economic sectors as well as drive innova-
tion in other companies (Hartshorn and Wheeler, 2002). KIBS sectors include 
computer services, R&D services, legal, accountancy, management services, 
architecture, engineering, technical services, advertising and market research 
(Miles, 2005). CTM application data shows that KIBS classes are among the 
classes which mostly sought trademark protection between 1996 and 2002 
(Mendonça, Pereira and Godinho, 2004). 
Examining the correlation between trademark and innovation success in KIS 
and KIBS a particularly strong and statistically significant correlation is found. 
The explanatory power is especially high for product innovations and trade-
marks are likely to be a suitable indicator of innovation in these sectors 
(Gotsch and Hipp, 2012). Schmoch (2003) finds a significant correlation be-
tween trademarks and the level of innovation, which is represented by the 
share of revenues with new products and services. As a next step subsectors 
were defined, namely technology-oriented services and knowledge-intensive 
services (KIS). While KIS companies have a significant correlation (5%) with 
marks and a low significant correlation with patents (10%), the opposite is true 
for technology-oriented services with a highly significant (1%) correlation with 
patents and a low significant correlation with trademarks (10%).  
After confirming the usefulness of trademarks as an indicator of innovation in 
services through theory and practical evidence, the next chapter connects in-
novation and growth statistics in order to measure innovation within compa-
nies.  
2.4 The Link between Innovation and Growth  
A major difficulty in observing innovation in growth statistics is the time lag be-
tween developing an invention and transforming it into measurable economic 
performance. Especially the long way from R&D as innovation input over pa-
tents as output of economic creativity to the commercialisation makes it diffi-
cult to link both indicators to sales or employment growth (Coad, 2009). Com-
panies have to undertake product development or may even delay this willing-
ly (Bloom and Van Reenen, 2002). However, trademarks are only filled shortly 
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before launching a new product and cover the commercialization of innova-
tion. Hence, they may overcome the time problem and provide an instant link 
between innovation and growth.  
In the following sales and employment growth are analysed separately since 
sales growth is an output and employment growth and input.  
2.4.1 Sales Growth  
A McKinsey Global Survey of Business Executives states that “[e]xecutives 
overwhelmingly say that innovation is what their companies need most for 
growth” (Carden, Mendonca, and Shavers, 2005, p. 17). Another survey ex-
amining SMEs find out that the most important strategy for expansion is in-
vestment in product innovation (Hay and Kamshad, 1994). While in economic 
theory innovation has been identified as a central aspect of sales growth 
(Klette and Griliches, 2000), finding empirical evidence is challenging.  
Mansfield (1962) undertook on of the first attempts by examining the steel and 
petroleum industries. Over a 40-year period he concludes that innovators 
grew more quickly, especially if they were small. Geroski and Machin (1992) 
provide similar results when looking at large quoted UK firms. Innovators are 
more profitable and grow than non-innovative firms. Another study compares 
patents and sales growth within the 365 large US corporations. It can be de-
termined that the patents positively influence sales growth and subsequently 
profits growth (Scherer, 1965). The influence of R&D on sales growth is stud-
ies by (Mowery, 1983) in the US manufacturing industry between 1921 and 
1946. Only between 1933 and 1946 a positive influence of R&D is observed 
and no difference between small and large companies can be determined. 
Roper's (1997) observations of small companies from the UK, Ireland and 
Germany show that a contribution by innovative products to sales growth.  
Overall, it can be determined that patents and R&D have several limitations 
when using them to measure sales growth. R&D is an innovation input and 
normally relatively smoothed over time. Patents have a skewed value distribu-
tion as well as a long time to market. These drawback result in a poor usage 
as indicators of innovation (Coad, 2009). To tackle this shortcomings, Coad 
and Rao (2008) create a variable to simulate innovativeness combing R&D 
and patents. The results challenge the importance of innovativeness for sales 
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growth and rather determine that it is only crucial for a few high-growth com-
panies. Similar results can be found in the pharmaceutical industries, where 
few blockbuster drugs generate huge profits, but median drugs have a nega-
tive net present value below R&D expenditures (Grabowski, Vernon, and 
DiMasi, 2002). 
2.4.2 Employment Growth 
The impact of innovation on employment growth is considered two-folded in 
literature. One the one hand process innovation goes along with an increase 
in productivity and may lower the required amount of labour. On the other 
hand product innovations are associated with employment increases. Hence, 
a differentiation between product and process innovation takes place in the 
recent innovation research. The impact of process innovation will be disre-
garded for the purpose of this study, since it can be assumed that trademarks 
are rarely filled for process innovations and that product innovations repre-
sents the majority of applications. Furthermore, indirect effects between the 
different forms of innovation on employment will be ignored.  
Looking at product innovations studies, many find a positive correlation with 
employment. Brouwer, Kleinknecht, and Reijnen (1993) examine product re-
lated R&D expenditures and prove a small positive effect on employment. 
Similar results are confirmed by Van Reenen (1997) and (Smolny, 1998) for 
manufacturing companies from the UK and Western Germany, respectively. A 
study in four European countries (France, Italy, the UK and Germany) be-
tween 1998 and 2000 examines manufacturing as well as service industries. 
While process innovation appears to have a negative effect, product innova-
tion is associated with employment growth in companies (Harrison, 
Jaumandreu, Mairesse and Peters, 2014). Overall, the evidence presented 
suggests a correlation between product innovation and employment growth, 
which will be tested in the following chapter. 
3. Empirical Analysis 
After providing a theoretical and empirical foundation the next chapter covers 
an empirical approach to understand the relationship between trademarks and 
innovation. Chapter 3.1 outlines the data used for this paper and chapter 3.2 
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explains the method used to gain further insights. Chapter 3.3 summarises 
the achieved results and differentiates between descriptive and growth statis-
tical analysis.  
3.1 Data 
This paper brings together three different data sources: 1) trademarks data, 2) 
patent data and 3) economic company data. The following chapter will de-
scribe the different data sources as well as the preparation of the data that 
took place in order to perform different statistical analysis.  
For international comparable trademark statistic, the OHIM database was 
used. While it is biased towards European companies, it offers many analyti-
cal advantages. Firstly, all trademark applications are evaluated the same 
way and no combination of different criteria takes place, which happens when 
combining different data sources. Secondly, the OHIM data is freely available 
and presents a huge amount of comparable data. In particular the information 
regarding the status of the trademark, its filing, registration as well as expiry 
date and the kind of trademark are relevant for the statistical analysis. Overall, 
the database consists of 1.077.613 trademark applications between the years 
1996 and 2013. Table 1 demonstrates the different status of the applications 
for a CTM.  
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Status Frequency Percent 
Appeal pending  455  0,04 
Application opposed  10.599  0,98 
Application published  401  0,04 
Application refused  38.595  3,58 
Application under examination  93  0,01 
Application withdrawn  98.208  9,11 
Registered  801.959  74,42 
Registration cancellation pending  2.172  0,2 
Registration cancelled  1.532  0,14 
Registration expired  120.195  11,15 
Registration pending  67  0,01 
Registration surrendered  3.337  0,31 
Total  1.077.613  100 
Table 1: Trademark status of complete OHIM database  
The most frequent status are ‘Registered’, ‘Registration expired’, ‘Application 
withdrawn’ and ‘Application refused. Table 2 demonstrates the different types 
of the whole database. 
Type Frequency Percent 
3-D  6.935  0,64 
Colour  813  0,08 
Figurative  416.142  38,62 
Hologram  9  <0,00 
Olfactory  7  <0,00 
Other  634  0,06 
Sound  200  0,02 
Word  652.873  60,59 
Total  1.077.613  100 
Table 2: Trademark features of complete OHIM database  
The most frequent used types of trademarks are word and figurative trade-
marks representing over 99% of the different trademark types.  
The company information are provided by the Bureau van Dijk database. 
Based on the Bureau van Dijk ID (BVDID) various information are assigned to 
a company, namely the foundation date, the last information date, sales and 
employment information between the years 2005 to 2014 and the NACE clas-
sification. The NACE information has advantages over the NICE classification 
of trademarks, because it more detailed with 615 classes compared to 45 
classes. Furthermore, it assigns each company specifically to one industry, 
while a trademark can have several NICE classes. Regarding the company 
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information it is important to know that the sales and employment data is not 
















Pharmaceutical 208 266 26 
IT-service 682 1104 266 
Overall 890 1817 292 
Control Group 
Pharmaceutical 63 95 37 
IT-service 149 224 62 
Overall 212 319 99 
Table 3: Overview of available growth data  
Only 292 companies in the trademark group and 99 companies in the control 
group neither have sales nor employment data (taking into account the calcu-
lations of a CAGR, see chapter 3.2 Methodology).  
As a next step the CTM data and company data is merged using the ‘OHIM-
BVDID’ table, which assigns each trademark application to the respective 
company. By keeping the complete merges as well as the incomplete ones 
(containing only companies without trademark applications) a database with 
two groups is created. Firstly, firms which applied for trademarks and have 
available economic information (merge = 3, called ‘trademark group’ / control 
= 0) and secondly, companies which did not apply for a trademark and have 
available economic information (merge = 1, called ‘control group’ group’ / con-
trol = 1). The trademark group consists of 621.810 applications form 196.594 
companies and the control group of 73.936 companies. 
Based on the literature discussion above (see chapter 2.3 Trademarks in In-
novation Research) the pharmaceutical and IT-Service industry reveal them-
selves as interesting industries to study. In his examination of Swedish com-
panies Malmberg (2005) identifies the pharmaceutical industries as a strong 
user of patents as well as trademarks. Various studies examine KIS and KIBS 
and find positive correlation between innovation and trademarks (Gotsch and 
Hipp, 2012; Mendonça, Pereira, and Godinho, 2004; Schmoch and Gauch, 
2009). According to the definition of Miles (2005) the IT-service industry, as a 
computer service, qualifies as a KIBS and furthermore, is a service industry 
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that registers a relatively high number of patents. Hence, the German phar-
maceutical and IT-service industries are selected for further studies due to the 
evidence found in other papers.  
Hence, the new database is filtered for the German pharmaceutical and IT-
service companies and only registered trademarks are kept which leaves 
7.235 observations.  
 











Table 4: Distribution of companies among different groups and industries 
The trademark group represents 1.667 companies with 6.816 registered 
trademarks and the control group 429 companies of the whole dataset. The 
source for the patent data is the European Patent Office (EPO). The ad-
vantages of using the EPO database are similar to the OHIM database. First-
ly, EPO and OHIM cover roughly the same geographic area, including Ger-
many. Secondly, based on the BVDID the database provides a good over-
view, which European patens companies hold. Thirdly, the EPO data is freely 
available in an electronic form. The overall database comprises 1.355.949 pa-
tent entries from various European companies. Each objective was merged 
with the priority information in order to determine the filing date and hence the 
expiry date. Based on this information a count of patents by company was 
created, giving the number of valid patents for each year between 2005 and 
2014. As a next step the complete patent information was merged with the 
trademark and control group. After the merge, companies with and without 
patents were kept. Overall 620 companies from the dataset hold valid 22.842 
patents (see appendix 1).  
After the data preparation the dataset contains data of companies from the 
German pharmaceutical and IT-service sector regarding economic information 
like sales and employment, trademark information as well as patent infor-
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mation. Based on the final database various statistical analyses are per-
formed. The methodology will be outlined in the next chapter. 
3.2 Methodology  
The description of the methodology is separated into two parts. Firstly, the 
descriptive and afterwards the growth analysis will be described.  
Descriptive	  Analysis	  
Regarding the descriptive analysis a few relevant steps have been taken. 
Firstly, in order to analysis sales and employment in a timely independent 
manner, only the latest available sales, respectively, employment data has 
been used. Furthermore, different division were created in order to reach a 
better understanding of the dataset. Firstly, a clustering of the companies us-
ing the number of registered trademarks was conducted. Based on these 
clusters various age, sales and employment analysis were conducted. Sec-
ondly, different age clusters were created to understand average number of 
trademarks based on the time a company existed. Thirdly, clusters based on 
sales were built in order to get an overview about the different sales groups. 
Fourthly, the same clustering was performed for employment. Fifthly, a classi-
fication regarding size was implemented. Moreover, differentiation along types 
of trademarks was made in order to identify different usage patterns. The 
classification in different groups (trademarks, age, size, sales, employment) 
follows the purpose to simplify descriptive analysis and make them easier to 
read and interpret.  
For the multiple regression analysis three different dummy variables were 
created, which function as the independent variables: 1) IT dummy (takes val-
ue 1 if IT-service company) 2) small dummy (takes value 1 if size equal or 
small than 100 employees) 3) age dummy (takes value 1 if company younger 
than six years). As a dependent variable the number of trademarks in compar-
ison to number of employees was chosen. With this variable it is possible to 
understand the influences of different factors on the number of trademarks 
and control for size effect through the employment information. 
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Growth	  Analysis	  
As a first step a count of number of trademarks was created for each compa-
ny, overall as well as segmented by type for. Next the complete data was col-
lapse by company and transformed into a time series in order to perform fur-
ther analysis. The time series covers the years 2005 to 2014 for every com-
pany and indicates in which year a certain type of trademark was filled. The 
structure of the time series allows differentiating by years since a trademark 
was filled.  
In order to fill gaps in growth data, a compounded annually growth rate 
(CAGR) as calculated. The CAGR allows evaluating growth statistics even if 
no data exists fro the respective year.  
Subsequently, the actual growth analyses were conducted. For the trademark 
group, only growth rates were used that lay within a ten-year time frame after 
the filing of a registered trademark. This follows the results of Millot (2009) re-
garding the long-term effect of trademarks. The usage of the filing year, and 
not the registration year, is explained by the possibility to directly use a 
trademark and that trademarks are filled shortly before usage (Hipp and 
Grupp, 2005; Mendonça, Pereira and Godinho, 2004).   
Generally, an overall analysis was performed as well as a separate analysis 
of the pharmaceutical and IT-service industries. In order to allow comparison 
with the control group two different outputs were used for the growth statistics. 
Firstly, an analysis was conducted which estimates the average growth rela-
tive to the year a trademark was filled (examination of year 1 to year 10 after 
the filing separately as well as growth averages of the years 1-5, 6-10 and 1-
10). However, this analysis does not allow a direct comparison between the 
trademark group and the control group because the control companies did not 
file trademarks and thus do not have a filing year. Hence, a second analysis 
was performed comparing the trademark and the control group year by year 
(from 2006 to 2014).  
After the initial general analysis between trademark and control group, growth 
averages were used for the comparison of different sub categories. Firstly, a 
differentiation took place between small and medium business (SMB) and big 
corporation. The objective is to understand the impact of innovation on small 
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companies and if trademarks are more suitable as an indicator such firms 
(Krasnikov, Mishra, and Orozco, 2009; Mansfield, 1962). Companies with 100 
or less employees were subsequently classified as SMBs.  
Along the same objective a separation between young and old companies 
took place. For this purpose the companies were divided in three different 
groups: 1) younger or equal to 5 years, 2) between 6 and 10 years and 3) 
older than 10 years. The age analysis was adapted on a year-to-year basis 
where the companies became older within the time series.  
In order to evaluate the impact of different type of trademarks, a comparison 
between growth statistics for word, figurative and other trademarks was con-
ducted. Other trademarks are defined as 3D, colour and sound and group be-
cause of their limited appearance within the dataset. 
The last part of the empirical studies covers with the relationship of trade-
marks, patents and growth statistics. As a first step a yearly patent and count 
for each company was created. Based on this count various correlation and 
growth analysis were performed. 
After explaining the methodology of the various analyses the next section pre-
sents the outcome and empirical results of this study.  
3.3 Results   
The following results are split into two parts. Firstly, a descriptive analysis is 
presented regarding the dataset, the trademarks, companies divided by indus-
try as well as sales and employment information. The second part outlines the 
performed growth analyses for the trademark and control group.  
3.3.1 Descriptive analysis 
The dataset consist of 2.291 companies.  
Absolut  




vices   
Trademark  
Group 292 1.375 
1.667 Trademark  
Group 
14% 66% 1667 
Control 
Group 136 293 
429 Control 
Group 
6% 14% 429 
 
428 1.668 2.096  20% 80% 2.096 
 
Table 5: Absolute and relative number of companies within the trademark and control 
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Hereof 1.667 companies are within the trademark group and 429 companies 
are in the control group. Overall, 428 companies are from the pharmaceutical 
industry and 1.668 from the IT-service industry. Table 5 reveals that overall 
the dataset contains 4 times as many IT-service companies as pharmaceuti-
cal companies. 
Intellectual Property Right Distribution  
Table 6 outlines the number of trademarks and patents within each group, giv-
ing a split by industry and group. A notable fact is that the absolute number of 
trademark and patents is higher for the pharmaceutical industry than the IT-
Service industry, which is caused by the higher number of IPRs for pharma-
ceutical companies. 
 















Pharmaceutical 3.829 13,1 292 17.714 121,3 146 
IT services 2.918 2,1 1.375 596 4,5 130 
Overall 6.747 4,0 1.667 18.310 66,3 276 
Control 
Group 
Pharmaceutical - - - 4.065 32,2 126 
IT services - - - 467 2,1 218 
Overall - - - 4.532 13,1 344 
Table 6: Trademark and patent distribution 
Furthermore, a pharmaceutical company has on average 9,3 patents per 
trademark, while for the IT-service industry the same ration is much lower with 
2,1 patents per trademark. These evidence show that both industries rely on 
the usage of trademarks as well as patents; however, the IT-service industry, 
as a KIBS, uses relatively more trademarks and thus confirms findings from 
previous studies (see chapter 2.3.2 Trademarks in the service industry).  






Overall Pharmaceutical IT-Service 
# % # % # % 
1 939 56,33 94 32,19 845 61,45 
2 331 19,86 45 15,41 286 20,8 
3 108 6,48 21 7,19 87 6,33 
4 70 4,2 20 6,85 50 3,64 
5 41 2,46 13 4,45 28 2,04 
6 23 1,38 9 3,08 14 1,02 
7 29 1,74 12 4,11 17 1,24 
8 18 1,08 10 3,42 8 0,58 
9 15 0,9 6 2,05 9 0,65 
10 13 0,78 9 3,08 4 0,29 
]10-20] 48 2,88 31 10,62 17 1,24 
]20-50] 18 1,08 9 3,08 9 0,65 
]50-100] 6 0,36 5 1,71 1 0,07 
>100 8 0,48 8 2,74 - - 
Total 1.667 100 292 100 1.375 100 
Skewness 17,07 7,30 9,76 
Kurtosis  336,64 61,60 153,89 
Table 7: Trademark cluster overall and by industry 
Firstly, it is noticeable that no IT-service company has more than 100 trade-
marks and that more than 61% only have a single one. Almost 90% of the 
companies have three or less trademarks. In the pharmaceutical industry over 
80% of the companies have between one and ten trademarks. These findings 
are confirmed by the skewness and kurtosis of the two distributions. The dis-
tribution of trademarks in pharmaceuticals is more evenly than in IT-services 
and the tail of the IT-service is much heavier showing that the tail is relatively 
longer. This adds that the IT-service companies only use a more limited num-
ber of trademarks compared to pharmaceuticals and that companies with a 
high number are relatively rare.  
Also the usage of different type of trademarks reveals interesting difference 
between the industries. 
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Year 2014 Overall Pharmaceutical IT-service 
Type # % # % # % 
3-D 16 0,23% 16 0,41% 0 0,00% 
Colour 1 0,01% 1 0,03% 0 0,00% 
Figurative 1344 19,72% 555 14,35% 789 26,76% 
Sound  3 0,04% 3 0,08% 0 0,00% 
Word 5452 79,99% 3.293 85,13% 2159 73,24% 
Overall 6.816 100% 3.868 100% 2.948 100% 
Table 8: Types of trademarks 
Looking at table 8 it becomes obvious that pharmaceutical not only use more 
trademarks, but also more advanced ones. While IT-service companies use 
only word and figurative trademarks, pharmaceutical ones rely on 3-D figures, 
colours and sounds, even though in very small numbers. This confirms the 
observation that pharmaceutical companies are heavier users of trademarks, 
not only in number but also in types. Interestingly, the usage of figurative 
trademarks is relatively higher in IT-service with 27% compared to 14%. Hol-
ograms, olfactory (scents) and any other form of trademarks are not used by 
any of the two industries. After studying the different types of trademarks on 
an individual basis, the next step is to analyse the composition within the 




tions # % 
Trademark 
Type Combina-
tions # % 
Trademark 
Type Combina-
tions # % 
fig 307 18,42 fig 41 14,04 fig 266 19,35 
word 987 59,21 word 138 47,26 word 849 61,75 
word_fig 366 21,96 word_fig 106 36,3 word_fig 260 18,91 
word_fig_other 6 0,36 word_fig_other 6 2,05 word_fig_other 0 0 
word_other 1 0,06 word_other 1 0,34 word_other 0 0 
Total 1.667 100 Total 292 100 Total 1.375 100 
Table 9: Combination of different trademark types 
Examining table 9 is clearly demonstrates that the single usage of word 
trademarks is by far the most frequent combination. Especially in the IT-
service industry over 60% of the companies solely use word trademarks. Re-
garding the second most used combination differences in the industries are 
noticeable. While in the pharmaceutical industry the word & figurative combi-
nation is used by 36% of the companies, companies in the IT-service industry 
evenly use solely figurative or a combination of word and figurative trade-
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marks. 3-D, colour and sound trademarks appear only in combination with 
word or word and figurative trademarks and only in the pharmaceutical indus-
try. 
The next part covers the distribution of patents overall and within the indus-
tries (table 10). Similar to the pattern of trademarks, the pharmaceutical indus-
try is a heavier user of patents. 
 
npat_cluster Overall Pharmaceutical IT-Service 
# % # % # % 
1 233 38% 51 20% 182 50% 
2 121 19% 42 16% 79 22% 
3 49 8% 20 8% 29 8% 
4 43 7% 21 8% 22 6% 
5 24 4% 11 4% 13 4% 
6 16 3% 11 4% 5 1% 
7 10 2% 6 2% 4 1% 
8 10 2% 5 2% 5 1% 
9 6 1% 3 1% 3 1% 
10 4 1% 2 1% 2 1% 
]10;20] 41 7% 28 11% 13 4% 
]20;50] 28 5% 23 9% 5 1% 
]50;100] 10 2% 9 3% 1 0% 
]100;[ 26 4% 26 10% - - 
Total 2.260 100 258 100 363 100 
Average # of 
Patents 35,78 79,05 3,01 
Table 10: Patent distribution 
While over 50% of the IT-services have only one patent, the same is only the 
case for 20% of the pharmaceutical companies. Moreover, 44% have more 
than 5 patents and 10% even more than 100. None IT-service company has 
that many patents. This difference in distribution is also reflected in the aver-
age number of trademarks with 79 respectively 3 patents per company (if 
trademark and control group are combined).  
The correlation between the count patents and the count of trademarks re-
veals a moderately high value of 0,5202. This is in line with the previous find-
ings of the dataset that the trademark group is a heavier user of patents than 




     Patent Trademark 
   Patent 1   
   Trademark 0,5202 1 
   Pharmaceutical IT-Services 
  Patent Trademark   Patent Trademark 
Patent 1   Patent 1   
Trademark 0,5163 1 Trademark 0,1814 1 
Table 11: Correlation between patents and trademarks 
The IT-service industry, however, has a low coefficient of only 0,1814. Hence, 
the linear relation is positive, but very weak. To get a better understanding, 
the companies were analysed in absolute and relative terms regarding their 
IPR holdings.  
Year  
2014 
Group Overall Pharmaceutical IT-Services 
Patent No Patent Patent No Patent Patent No Patent 
Absolute Trademark 271 1396 141 151 130 1245 
No Trademark 318 111 108 28 210 83 
Relative Trademark 13% 67% 33% 35% 8% 75% 
No Trademark 15% 5% 25% 7% 13% 5% 
Table 12: IPR holdings of companies by industry 
Table 12 show that one third of the pharmaceutical companies combine pa-
tents and trademark, while 60% rely on only one of the two. IN the IT-service 
industry, however, over 88% of the companies use only one form of IPR (13% 
patents, 75% trademarks) and only 8% combine the two forms. Interestingly, 
the share of companies within the pharmaceutical industry is higher than in 
the IT-service industry with 7% and 5%, respectively. The regression analysis 
confirms this picture. The influence of patents on trademarks in the pharma-
ceutical industry is much higher, which is indicated by the patent coefficient of 




    ntrade Coef Std. Error P>|t|  
    count_pat 4,4069270 .1580888 0,000 
    Const -3,4330230 2.931.887 0,242 
    
        Number obs 2.096 
      R-squared 0,2707 
      
        Pharmaceutical IT-service 
ntrade Coef Std. Error P>|t|  ntrade Coef Std. Error P>|t|  
count_pat 4,4485810 .3575017 0,000 count_pat .1558918  .0207099 0,000 
Const 10,6819800 1.444.338 0,460 Const .3617692 .0757579 0,000 
        




  R-squared 0,2666 
  
R-squared 0,0329 
  Table 13: Linear regression of number of patent count on number of trademarks 
Furthermore, the r-squared it higher for the pharmaceutical industry, showing 
that 23% (0,26 – 0,03) more of the variation is explained by patents in this in-
dustry. In general the findings of Malmberg (2005) study of the Swedish 
pharmaceutical industry are confirmed and we find a correlation between the 
number of patents and trademarks, indicating that innovative firms in this in-
dustry rely on trademarks (see also appendix 2 – 4). The findings regarding 
the IT-service industry are inconclusive, since the number of patents is rela-
tively low and hence the mutual usage of patents and trademarks is not widely 
adopted. This confirms previous studies of the KIBS and shows that a new 
indicators are need (Gotsch and Hipp, 2012; Hipp and Grupp, 2005; Schmoch 
and Gauch, 2009). 
Age Distribution 
The next analysis examines the age of companies and its distribution in the 
dataset. Firstly, a classification into three different age groups was performed: 
1) age group 0 – 5 2) age group 6 – 10 3) age group older than 10. Based on 
this classification the distribution along the age was conducted (see table 14). 
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Pharma 32 31 229 292 Pharma 1,92% 1,86% 13,74% 17,52% 
IT-Service 553 587 235 1.375 IT-Service 33,17% 35,21% 14,10% 82,48% 






Pharma 17 17 102 136 Pharma 3,96% 3,96% 23,78% 31,70% 
IT-Service 103 55 135 293 IT-Service 24,01% 12,82% 31,47% 68,30% 
 Total 120 72 237 429  Total 27,97% 16,78% 55,24% 
100,00
% 
Table 14: Age distribution by industry and group 
The distribution of young companies in the IT-service industry attracts atten-
tion. Whereas 20% of the pharmaceutical companies in the control group are 
between the age of 0 and 10, in the IT-services over 80% are within this age 
group. In contrast young IT-service companies in the control group represent 
only 53% and young pharmaceutical companies 25%.  
Next the distribution of trademarks within different age clusters was examined. 
Firstly, one notices that the number of trademarks rises with the age of com-
panies and that the pharmaceutical companies are on average more than 30 
years older than the IT-service companies 
Year 2014 Pharmaceutical IT Services 
Age Cluster Trademarks Std. Error Observations Trademarks Std. Error Observations 
0 - - - 1,3 0,097353 50 
1 2,7 1,085766 10 1,3 0,0683595 156 
2 2,3 0,521641 7 1,5 0,1197788 162 
3 5,6 3,316288 8 1,6 0,1299780 97 
4 3,2 1,019804 5 3,1 1,1471090 63 
5 2,0 1,000000 2 1,7 0,1733917 59 
6-10 2,7 0,452917 31 2,2 0,2253122 235 
10-15 4,8 1,024892 32 2,6 0,2157126 273 
15-25 12,2 7,962178 58 2,8 0,2605792 200 
25-50 9,9 2,715817 53 2,7 0,4182443 63 
50-100 16,1 6,296452 58 2,5 0,5000000 2 
>100 47,7 1,845067 27 - - - 
Mean Age 39,38 9,25 
Skewness 2,13 -0,15 
Kurtosis  7,07 1,47 
Table 15: Trademark distribution by age and industry 
Moreover, the age has a much lower impact on the number of trademarks of 
an IT-service company compared to pharmaceutical companies. While the 
number of trademarks rises only by 1,2 between the age cluster 1 and 50-100 
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for IT-service companies, in the pharmaceutical industry the number trade-
marks rises by 45. This is also reflected in the skewness and kurtosis of in-
dustries. The skewness of IT-services is almost zero indicating an even distri-
bution in contrast to 2,13 of pharmaceuticals. Furthermore, the kurtosis is big-
ger for pharmaceutical companies, showing that the distribution has more 
peaked than the other industry.  
A linear regression analysis extends the insights about the relationship be-
tween age and number of trademarks. For the regression the age was used 
as the dependent variable and number of registered trademarks (more pre-
cisely the average number of trademarks by age) as the independent variable. 
The scatterplot combines age with the number of trademarks. The following 
tables and graphics outline the results of the regression analysis for the over-
all dataset as well as the two industries. 
 Mean_ntrade Coef Std. Error P>|t|  
Age 0,3031460 0,0154798 0,000 
Const -0,3415158 0,3991046 0,392 
    Number obs 1.651 
  R-squared 0,1887 
  Table 16: Linear regression of average number trademarks by age for the overall da-
taset 
 















In the overall dataset each year a company ages increases the number of 
trademarks on average by 0,327. While the R-squared is relatively low with a 
value of 0,125, the age coefficient is significant at a 1% level.  
 
 Mean_ntrade Coef Std. Error P>|t|  
Age 0,3271566 0,0509051 0,000 
Const 0,1630847 2,8130320 0,954 
    Number obs 291 
  R-squared 0,1250 
  Table 17: linear regression of number trademarks by age for pharmaceutical industry 
 
Graphic 2: Scatterplot comparing age and number of trademarks for the pharmaceu-
tical industry 
The pharmaceutical industry has a slightly higher age coefficient, which again 
is significant at 1% level. The R-squared is even lower than the one for the 
overall dataset and furthermore, the scatter graph show that the outliers are 
mostly companies from the pharmaceutical industry.  
 Mean_ntrade Coef Std. Error P>|t|  
Age 0,0519178 0,0020743 0,000 
Const 1,6725870 0,0257042 0,000 
    Number obs 1.360 
  R-squared 0,3157 

















Graphic 3: Scatterplot comparing age and number of trademarks for the IT-service 
industry 
The IT-service companies have a much lower age coefficient, which increase 
the number of trademarks only by 0,05 for each year, but is still significant at a 
1% level. Yet, the R-squared is the highest among the three linear regres-
sions and indicates a positive linear correlation between age and number of 
trademarks.  
Sales Distribution 
Next a closer look at the distribution of sales will be taken. Firstly, the compa-
nies were divided into different sales cluster to gain a first overview. Almost 
86% of the IT service companies make less than € 10 million, while more than 
50% of the pharmaceutical companies make more than € 10 million. This is 
also reflected in the average sales with € 530 million and € 12 million, respec-
tively (see Appendix 6). Table 19 gives an overview of the sales distribution 











[in 000 €] Pharmaceuticals IT-services 
# Trademarks Sales Std. Error Observations Sales Std. Error Observations 
1 44.706 18.229 61 9.155 4.615 436 
2 89.449 57.408 32 5.075 802 170 
3 125.005 90.320 16 7.929 1.671 62 
4 34.962 26.612 13 4.578 1.094 39 
5 25.340 8.455 11 7.190 1.984 18 
6 48.891 12.621 9 24.741 12.218 12 
7 44.162 17.722 11 21.775 10.658 11 
8 237.768 174.345 10 474.995 452.942 5 
9 82.326 53.330 5 28.686 18.201 5 
10 400.470 143.323 8 22.939 11.198 3 
10-20 619.541 319.952 27 24.668 7.601 16 
20-50 155.979 42.847 7 33.651 8.967 8 
50-100 2.033.058 1.605.881 3 - - 1 
>100 9.758.783 5.007.908 8 - - - 
Average Sales 
per Trademark 33.650 6.492 
Table 19: Sales distribution by number of trademarks and industry 
Besides two outliers in each industry in the ‘8 trademarks’ group, pharmaceu-
tical companies generate more sales in each trademark group. This difference 
becomes clearer especially from ten trademarks onwards, when the gap in-
creases extremely. The disparity is also reflected when examining the linear 
relations between the number of trademarks and average sales. Overall, a 
positive relation is found where each added trademark generates on average 
€ 40,6 million in sales, which is significant at a 1% level. The R-squared is 
high with a value of almost 0,5 and by the scatterplot some outliers are re-
vealed which have more than 200 trademarks. Similar results are found for 
the pharmaceutical industry, which dominates the overall analysis due to its 
large values (table 20). The sales impact of each added trademark is even 
higher compared and the R-squared is almost the same. The coefficient is 
significant at a 1% level. Looking at the IT-services one notices that the num-




 	   	   	  sales Coef Std. Error P>|t|  
	   	   	   	  ntrade 40.587,55 1.318,86 0,000 
	   	   	   	  Const -92.821,16 34813,76 0,000 
	   	   	   	  
    	   	   	   	  Number obs 1.007 
  	   	   	   	  R-squared 0,4852 
  	   	   	   	  
    	      Normal Normal 
sales Coef Std. Error P>|t|  sales Coef Std. Error P>|t|  
ntrade 41.512,75 2.882 0,000 ntrade 1.499,28 913 0,101 
Const -116.280,00 160.161,2 0,469 Const 8.238,36 4.515,3 0,068 
        Number obs 221 
  
Number obs 786 
  R-squared 0,4865 
  
R-squared 0,0034 
  Table 20: Linear regression of average sales by number trademarks for the overall 
Each added trademark only adds € 1,5 million in sales to the company and 
furthermore, the coefficient is not significant. This disparity is also visible in 
the average sale per trademark. With € 33,65 million the indicator of pharma-
ceuticals it is more than five times higher than the IT-services one. Comparing 
the sales per trademark in each group, it seems that this figures is declining 
with the number of trademark. Ignoring ‘8 trademark’ group with two outliers, 
the highest figures are in the ‘1 trademark’ and ‘2 trademark’ group. Based on 
these findings it seems that there is a natural limit for sales, respectively, 
productivity per trademark in an industry. One explanation for the lower figure 
of IT-services could be the relation of services to human input, which nega-
tively influences scalability. 
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Sales per trademark Pharmaceutical IT Services 
# trademarks Sales Std. Error Observations Sales Std. Error Observations 
1 44.706 18.229 61 9.155 4.615 436 
2 44.725 28.704 32 2.538 4.008 170 
3 41.668 30.107 16 2.643 5.568 62 
4 8.741 6.653 13 1.144 2.734 39 
5 5.068 1.691 11 1.438 3.968 18 
6 8.148 2.104 9 4.124 2.036 12 
7 6.309 2.532 11 3.111 1.523 11 
8 29.721 21.793 10 59.374 56.618 5 
9 9.147 5.926 5 3.187 2.022 5 
10 40.047 14.332 8 2.294 1.120 3 
10-20 44.350 24.685 27 1.880 6.049 16 
20-50 4.962 1.086 7 1.420 4.393 8 
50-100 33.615 26.910 3 53 - 1 
>100 37.908 15.191 8 - - - 
Average Sales per 
Trademark 33.650   221 6.492   786 
Table 21: Average sales per Trademark by industry 
The regression of average sales per trademark and number of trademarks 
confirms the finding of table 21 and reveals that there is no linear relationship 
between the two variables and that the sales per trademark are independent 
of the number of trademarks (table 20 – 21). 
Normal 
 	   	   	  sales_ntrade Coef Std. Error P>|t|  
	   	   	   	  ntrade 87,94 102,28 0,390 
	   	   	   	  Const 11.978,24 2.700 0,000 
	   	   	   	  
    	   	   	   	  Number obs 1.007 
  	   	   	   	  R-squared 0,0007 
  	   	   	   	  
    	      Normal Normal 
sales_ntrade Coef Std. Error P>|t|  sales_ntrade Coef Std. Error P>|t|  
ntrade 2,18 143 0,988 ntrade -240,18 609 0,693 
Const 33.616,17 7.945,5 0,000 Const 7.096,93 3.010,1 0,019 
        Number obs 221 
  
Number obs 786 
  R-squared 0,0000 
  
R-squared 0,0002 
   
Table 22: Linear regression of sales per trademark by trademark group for the overall 




Graphic 4: Scatter graph comparing # trademarks and average sales per trademark 
 
 Graphic 5: Scatter graph comparing # of trademarks and average sales per trade-
mark for the pharmaceutical industry 
 
Graphic 6: Scatter graph comparing # of trademarks and average sales per trade-
mark for the IT-service industry 
The scatterplots, however, reveal an interesting insight. The variance of sales 
per trademark is the highest when the number of trademarks is low. Within the 
pharmaceutical industry this phenomena is especially strong compared to the 
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Employment Distribution 
After analysing sales information the following part deals with employment in-
formation. Firstly, the companies are divided by number of employees (see 
Appendix 7). As inferred from the previous data, the pharmaceutical compa-
nies have on average more employees. While 37% (108 companies) have 
more than 100 employees, the same is only true for 12% (169 companies) of 
the IT-service industry. On average a pharmaceutical company employs 
1.131 people and an IT service one only 40, a difference of more than 1.000 
employees per company.  
Emp Pharmaceutical IT-Services 
# trademarks Emp Std. Error Observations Emp Std. Error Observations 
1 74 17,1 89 26 3,4 794 
2 215 117,4 45 32 4,1 272 
3 274 166,2 21 41 6,4 84 
4 32 9,1 20 41 6,4 50 
5 125 45,8 13 44 10,9 28 
6 209 52,0 9 122 51,5 14 
7 177 82,8 12 40 9,8 16 
8 774 564,6 10 845 768,3 8 
9 201 76,1 6 222 126,9 9 
10 958 346,8 9 114 25,4 4 
10-20 933 373,6 31 146 45,8 17 
20-50 456 165,4 9 201 64,0 9 
50-100 12.741 12.383,0 4 12 - 1 
>100 24.222 14.232,5 8 - - - 
Average Emp 
per Trademark 69,9 21,9 
Table 23: Employment by # of trademarks 
This is also reflected in the average employment per trademark in the indus-
tries. While IT-services are comparably low with 21,9 the pharmaceutical 
companies employ more than three times as many people per trademark, 
namely 69,9. The employment information overall are in line with the sales 
information, were the pharmaceutical industry was strictly bigger than the IT-




	   	   	   	  emp Coef Std. Error P>|t|  
	   	   	   	  ntrade 113,38 3,00960 0,000 
	   	   	   	  Const -237,42 63,81140 0,000 
	   	   	   	  
    	   	   	   	  Number obs 1.592 
  	   	   	   	  R-squared 0,4716 
  	   	   	   	  
        Pharmaceutical IT-Service 
emp Coef Std. Error P>|t|  emp Coef Std. Error P>|t|  
ntrade 116,66 7,2739 0,000 ntrade 7,41 1,55003 0,000 
Const -415,32 358,1973 0,247 Const 23,52 6,38157 0,000 
        Number obs 286 
  
Number obs 1.306 
  R-squared 0,4753 
  
R-squared 0,0172 
  Table 24: Linear regression of employment by trademark group for the overall da-
taset and by industry 
The results from conducting a linear regression for employment using number 
of trademarks as a independent variable shows that the number of employees 
rises with the number of trademarks. While all coefficients are significant at a 
1% level, the impact in pharmaceuticals with 116,6 is much higher than in IT-
service with 7,4. The quality of the regression is high overall and for pharma-
ceuticals with 0,4716, respectively, 04753 and low for IT-Services with an R-
squared of 0,0172.  
Size Distribution 
The next descriptive part is a short description of the dataset regarding size of 
the company. Small companies are defined by their number of employees, 
whereas 100 employees or less is defined as small.  
Group Absolute Big Small   Relative Big Small   
Trademark 
Group 
Pharma 108 184 292 Pharma 6,48% 11,04% 17,52% 
IT-Service 169 1.206 1.375 IT-Service 10,14% 72,35% 82,48% 
  277 1390 1.667   16,62% 83,38% 100,00% 
Control 
Group 
Pharma 51 85 136 Pharma 11,89% 19,81% 31,70% 
IT-Service 25 268 293 IT-Service 5,83% 62,47% 68,30% 
  76 353 429   17,72% 82,28% 100,00% 
Table 25: Distribution of companies by size 
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Distinguishing between trademark and control group a few things are noticea-
ble. Firstly, within the pharmaceutical industry small and big companies are 
more evenly distributed compared to the IT-service sector. This applies to the 
trademark group as well as the control group. Secondly, within the control 
group, the share of big IT-service companies is even smaller then in the 
trademark group. Overall, big companies account for 17% roughly of the 
whole dataset. 
Linear regression model for number of trademarks 
As the last part of the descriptive analysis a multiple linear regression model 
was build. The purpose of the model is to understand different factor that in-
fluence the number of trademarks a companies maintains. In order to account 
for size effects, the number of trademarks in relation to number of employees 
was used as the dependent variable.  
 
ntrade_emp Coef. Std. Err.  t P>t 
it_dummy -0,3305668 0,0909627 -3,63 0,000 
small_dummy 0,4929355 0,1050596 4,69 0,000 
age5_dummy 0,4347202 0,0711201 6,11 0,000 
_cons 0,172988 0,1015743 1,70 0,089 
     Number of 
obs 1.592 
   R-squared 0,044 
   Table 26: multiple linear regression model for numbers of trademarks 
The different independent variable explain certain relationships: 1) being an 
IT-service company reduces the number of trademarks on average by 0,33, 2) 
small companies hold on average 0,49 trademarks more than big ones and 3) 
companies existing for only five years or less have normally 0,43 trademarks 
more than companies older than five years. All the presented factors are sig-
nificant at a 1% level.  
After the comprehensive description analysis of the dataset the following 
chapter explains the results from the growth analysis and gives an  
3.3.2 Growth Analysis 
The aim of the growth analysis is to examine the influence of trademarks on 
innovation, whereas innovation is proxied by sales and growth statistics. First-
 38 
ly and overview of the average growth rate in both industries is given in order 
to be able to correctly evaluate the achieved results and understand differ-




Growth Std Error Observations 
Sales 
Growth Std Error Observations 
Sales 1,270436 0,1040437 1.355 1,338445 0,0791139 3.323 
Emp 1,110557 0,0240025 1.966 1,315025 0,028753 6.041 
Table 27: Growth overview by industry 
IT-service companies experience stronger growth for sales and employment; 
however, the difference for employment compared to the pharmaceutical in-
dustries is higher. The results of the growth analysis are discussed in the fol-
lowing chapter. 
Growth Analysis by Trademark Usage 
Sales	  Growth	  
The first conducted analysis examines the growth rates in relation to the filing 
year of a trademark. Overall, companies achieve and average sales growth 
rate of 25,3% per year if within the 10 years after the filings. 
 
Trademark Group 
 Sales Growth Overall  
Year Mean Std Error Observations 
0 1,393630 0,103806 625 
1 1,241635 0,051017 451 
2 1,723295 0,5946702 376 
3 1,131758 0,0300594 285 
4 1,102606 0,0433874 223 
5 1,186093 0,0518987 201 
6 1,083122 0,0287965 152 
7 1,153168 0,0488037 131 
8 1,023696 0,0218073 112 
9 1,106979 0,0556911 85 
10 1,107802 0,0431564 79 
1-5 1,311701 0,1467173 1536 
6-10  1,094746 0,0179219 559 
1-10 1,253812 0,1076865 2.095 




Especially year 2 stands out with an average growth rate of 72,3% after filing 
a trademark. When the impact is evaluate only between years 1 to 5 the 
growth rates become even bigger. Examining the two industries some differ-
ences are noticeable (see table 29)  
 
Trademark Group 
Sales Growth   Pharmaceutical IT-Services 
Year Mean Std Dev Observations Mean Std Dev Observations 
0 1,1396250 0,0499543 259 1,5733780 0,1731951 366 
1 1,077463 0,0306557 130 1,308123 0,0702919 321 
2 1,079892 0,0298689 115 2,006787 0,85650 261 
3 1,142178 0,0608565 91 1,126870 0,0338052 194 
4 1,048554 0,0346507 65 1,124843 0,0595376 168 
5 1,235790 0,1314878 57 1,166421 0,0506824 144 
6 1,016611 0,0698143 39 1,106077 0,030245 113 
7 1,184507 0,1664348 29 1,144258 0,0418379 102 
8 0,931794 0,0615019 26 1,051480 0,0208162 86 
9 1,323529 0,2682857 17 1,052841 0,0185658 68 
10 1,267468 0,1692169 19 1,057241 0,0171885 60 
1-5 1,106533 0,0238889 458 1,398869 0,2087779 1.078 
6-10  1,113900 0,0618328 130 1,088942 0,014004 429 
1-10 1,108162 0,0230618 588 1,310642 0,1494216 1.507 
Table 29: Sales growth according to years after filing of trademark for the pharma-
ceutical and IT-service industries 
Firstly, when filing a trademark, the impact is much higher for IT-service com-
panies compared to with an average growth rate of 31%. In contrast, pharma-
ceutical companies average only at 10,8%. Companies in the IT-service in-
dustry experience the highest growth rate in the years 1 to 5 after filing a 
trademark while the contrary is true for pharmaceutical companies, which 
have the highest rate from year 6 to 10. However, the difference is smaller 
and the growth rates more evenly distributed.  Furthermore, this high overall 
growth rate in year 2 is explained by the high growth rate of the IT-service in 
the same year. In order to be able to evaluate these figures, a comparison 
with the control group is needed. Since a classification according to year after 
filing for a trademark is not possible for the control group, an analysis by year 
form 2006 to 2014 was conducted. Hereby, only growth rates for the control 
group were used if a trademark was filed within 10 years (see chapter 3.2 




Sales Growth Overall 
year Sales Growth Std Error Observations 
2006 1,219661 0,0717806 94 
2007 1,116229 0,0276543 136 
2008 1,152572 0,0305574 203 
2009 1,095034 0,0287948 319 
2010 1,098111 0,0195404 321 
2011 1,783332 0,6454814 347 
2012 1,190721 0,0428009 366 
2013 1,162398 0,0536441 266 
2014 1,411198 0,1796389 43 
1-5 / 2005-2014  1,311701 0,1467173 1536 
6-10 / 2005-2014 1,094746 0,0179219 559 
1-10 / 2005-2014  1,253812 0,107687 2.095 
Table 30: Trademark group sales growth according to year for the overall dataset 
Trademark Group 
Sales Growth Pharmaceutical IT-Services 
year Sales Growth Std Error Observations Sales Growth Std Error Observations 
2006 1,111670 0,379551 37 1,289761 0,1152695 57 
2007 1,064368 0,0380700 49 1,145438 0,0373296 87 
2008 1,201475 0,0763920 61 1,131565 0,0288997 142 
2009 1,130700 0,0695484 89 1,081233 0,0295749 230 
2010 1,015194 0,0292413 83 1,127027 0,0240525 238 
2011 1,062094 0,0252702 100 2,075331 0,9066205 247 
2012 1,186678 0,0932206 96 1,192158 0,0477312 270 
2013 1,125860 0,0810686 61 1,173271 0,0653667 205 
2014 0,943500 0,0876482 12 1,592243 0,2401272 31 
1-5 / 2005-2014  1,106533 0,0238889 458 1,398869 0,2087779 1.078 
6-10 / 2005-2014 1,113900 0,0618328 130 1,088942 0,014004 429 
1-10 / 2005-2014  1,108162 0,023062 588 1,310642 0,149422 1.507 
Table 31: Trademark group sales growth according to year for the pharmaceutical 
and IT-service industries  
Overall, the growth rates are the smallest in the years 2009 and 2010, which 
seam logical due to the financial crises. The year experiencing the highest 
growth is 2011; however, this is most likely caused by an outlier from the IT-
service industry. Considering the industries separately, especially the nega-
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tive growth rate for pharmaceuticals in year 2014 and the two high ones for IT 
services in 2011 and 2014 catch attention. Based on the years we can finally 
compare the trademark group with the control group.  
 
Control Group 
 Sales Growth Overall 
year Sales Growth Std Error Observations 
2006 1,055539 0,0482546 49 
2007 1,990039 0,6138458 68 
2008 1,139468 0,0550553 100 
2009 1,067678 0,0346761 135 
2010 1,325399 0,2210012 141 
2011 1,142397 0,0417490 141 
2012 1,099518 0,0358335 126 
2013 1,268853 0,1347996 73 
2014 1,099682 0,1970473 6 
2005-2014 1,228665 0,064657 839 
Table 32: Control group sales growth according to year for the overall dataset 
Control Group 
 Sales Growth Pharmaceutical IT-Services 
year Sales Growth Std Error Observations Sales Growth Std Error Observations 
2006 1,052775 0,0763858 25 1,058419 0,0598214 24 
2007 1,011044 0,0285870 23 2,490414 0,9219563 45 
2008 1,032761 0,0479414 32 1,189684 0,0772553 68 
2009 1,025725 0,0296840 43 1,087286 0,0489372 92 
2010 1,690233 0,6453582 48 1,137098 0,041661 93 
2011 1,087847 0,0413764 47 1,169672 0,0590624 94 
2012 1,056235 0,0209563 42 1,121160 0,0526811 84 
2013 1,058807 0,0292968 30 1,415396 0,2263299 43 
2014 0,744007 0,5131362 2 1,277519 0,1468268 4 
2005-2014 1,152746 0,106845 292 1,269193 0,081147 547 
Table 33: Control group sales growth according to year for the pharmaceutical and 
IT-service industries  
While there are some years in which the control group has higher sales 
growth rates than the trademark group, the aggregated growth rates of the 
trademark group are higher. Looking at the 1-5 year average, the difference 
becomes even greater.  
Comparing the two industries, a very interesting finding can be observed. 
While IT-service companies within the trademark group achieve higher growth 
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compared to the control group, the same is not true for pharmaceutical com-
panies. Table 34 demonstrates these differences.  
 
Group Overall     Difference Std Error Observations Pr(T > t) 
    1-5 0,0830359 0,2042032 2373 0,3422 
    1-10 0,025147 0,1750306 2.932 0,4429 
    
Group 
Pharmaceutical IT-Services 
Difference Std Error Observations Pr(T > t) Difference Std Error Observations Pr(T > t) 
1-5 -0,0462137 0,0903785 748 0,6954 0,1296768 0,2987755 1623 0,3322 
1-10 -0,044584 0,082062 878 0,7065 0,041449 0,2528205 2.052 0,4349 
Table 34: Differences in sales growth rates 
While no figure is significant the growth difference in IT-services is high with 
12,9%, respectively, 4%. Both industries combined achieve a difference of be-
tween trademark group and control group growth of 8%, respectively, 2,5% 
and for the pharmaceutical industry the difference is in both case around -
4,5%.  
The results for sales growth confirm the theoretical findings discussed in 
chapter 2. Trademarks seem to better predict growth rates and innovation in 
the IT-service companies, while a causality between trademarks and sales 
growth cannot be proved in the pharmaceutical industry. 
Employment	  Growth	  
Next, a closer look at the results of the growth analysis for employment is tak-
en. The conducted analyses for this purpose are the same as for the growth 
analysis. A first look for the combined rates reveals a particularly strong 
growth in the first 5 years. Looking at the average of the 10 years within the 
time of filing a trademark, it is noticeable that the employment growth rate is 
even higher than the one of sales, while the standard error is lower in compar-
ison. This shows that the growth rates of employment are less volatile.  
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Trademark Group 
 Emp Growth Overall  
Year Mean Std Error Observations 
1 1,337046 0,0624043 858 
2 1,489757 0,1507869 691 
3 1,294912 0,1151545 533 
4 1,191767 0,0586888 407 
5 1,343643 0,1365794 326 
6 1,083318 0,0486636 246 
7 1,174747 0,0983028 201 
8 1,267095 0,1127036 167 
9 1,182407 0,0969914 141 
10 1,043903 0,0218228 126 
1-5 1,346314 0,0502916 2815 
6-10 1,149235 0,0373512 881 
1-10 1,299337 0,0393467 3.696 
Table 35: employment growth according to years after filing of trademark for the 
overall dataset 
Examining the two industries separately (see table 36), the growth rates of IT-
service companies are again higher with 35,9% compared to 9,7%.  
 
Trademark Group  
Emp Growth Pharmaceutical IT-Services 
Year Mean Std Error Observations Mean Std Error Observations 
1 1,053924 0,0174643 192 1,418667 0,0799717 666 
2 1,047701 0,0183754 162 1,625131 0,1965511 529 
3 1,038751 0,0216382 132 1,379235 0,1527084 401 
4 1,024368 0,0281495 97 1,244147 0,0763376 310 
5 1,398438 0,3738643 83 1,324927 0,1320071 243 
6 1,233539 0,2137991 54 1,041068 0,0167955 192 
7 1,119884 0,0887481 39 1,187954 0,1201710 162 
8 1,139839 0,2036409 37 1,303314 0,1328824 130 
9 1,041495 0,0297833 28 1,217323 0,1206861 113 
10 1,033249 0,0777730 29 1,047088 0,0166611 97 
1-5 1,088033 0,0474215 666 1,426358 0,0641246 2.149 
6-10 1,131480 0,0766574 187 1,154020 0,0427058 694 
1-10 1,097558 0,0406454 853 1,359878 0,0496243 2.843 
Table 36: employment growth according to years after filing of trademark for the 
pharmaceutical and IT-service industries 
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Especially, the first five years experience particularly high growth, which is 
27% higher than for the last five years. For the pharmaceutical companies the 
growth rates are more evenly distributed; however, similar to the sales rates 
the last five years experience stronger growth than the first five years. For 
comparison reasons, next a division along the years 2006 to 2014 was made.  
 
Trademark Group  
 Emp Growth Overall 
year Sales Growth Std Error Observations 
2006 2,104638 1,046569 85 
2007 1,074999 0,033916 198 
2008 1,253820 0,084411 357 
2009 1,171170 0,043377 527 
2010 1,219935 0,056964 588 
2011 1,423596 0,107757 640 
2012 1,293028 0,099315 653 
2013 1,307491 0,071061 509 
2014 1,492814 0,141359 139 
1-5 / 2006 – 2014 1,346314 0,0502916 2815 
6-10 / 2006 – 2014 1,149235 0,0373512 881 
1-10 / 2006 – 2014 1,299337 0,0393467 3.696 
Table 37: Trademark group employment growth according to year for the overall  
dataset 
Trademark Group 
 Emp Growth Pharmaceutical IT-Services 
year Sales Growth Std Error Observations Sales Growth Std Error Observations 
2006 1,062046 0,0321473 34 2,799699 1,744204 51 
2007 1,012223 0,0226801 57 1,100377 0,046624 141 
2008 1,036531 0,0294909 98 1,336037 0,115467 259 
2009 1,015145 0,0207095 126 1,220196 0,056431 401 
2010 1,033220 0,0318149 133 1,274513 0,072848 455 
2011 1,263860 0,2054091 152 1,473350 0,126036 488 
2012 1,147801 0,0862667 133 1,330172 0,122732 520 
2013 1,102917 0,081457 94 1,353829 0,085053 415 
2014 1,040978 0,0415217 26 1,596776 0,172283 113 
1-5 / 2006 – 2014 1,088033 0,0474215 666 1,426358 0,0641246 2.149 
6-10 / 2006 – 2014 1,131480 0,0766574 187 1,154020 0,0427058 694 
1-10 / 2006 – 2014 1,097558 0,0406454 853 1,359878 0,0496243 2.843 
Table 38: Trademark group employment growth according to year for the  
pharmaceutical and IT-service industries  
Table 37 and 38 demonstrate the growth per year overall and by industry. In 
the pharmaceutical industry, the impact of the financial crises is noticeable 
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with the low growth rates. For the IT-Service companies especially year 2006 
is outstanding with a growth rate of 179,9%; however, the standard error is 
very high with 1,74 indicating and outlier, who is responsible for the extreme 
rate. Using the yearly growth rates, a comparison with the control group can 
be made.  
 
Control Group 
 Emp Growth Overall 
year Sales Growth Std Error Observations 
2006 1,143389 0,086618 49 
2007 1,165153 0,069893 110 
2008 1,064060 0,018951 164 
2009 1,057670 0,028974 222 
2010 1,215221 0,076575 243 
2011 1,170870 0,982436 237 
2012 1,966540 0,038690 202 
2013 1,198347 0,539734 122 
2014 1,030023 0,181878 29 
2005-2014 1,215198 0,0537377 1.378 
Table 39: Control group employment growth according to year for the overall dataset 
Control Group 
 Emp Growth Pharmaceutical IT-Services 
year Sales Growth Std Error Observations Sales Growth Std Error Observations 
2006 1,030023 0,064949 29 1,307771 0,187138 20 
2007 1,031378 0,026517 43 1,251009 0,112573 67 
2008 1,023360 0,013913 50 1,081911 0,026442 114 
2009 1,002104 0,024528 71 1,083797 0,040892 151 
2010 1,046639 0,024830 75 1,290480 0,109812 168 
2011 1,072379 0,045733 73 1,214710 0,140518 164 
2012 1,102482 0,047036 59 1,178535 0,051072 143 
2013 1,035329 0,043302 37 2,371890 0,771682 85 
2014 1,008342 0,008342 9 1,283850 0,263502 20 
2005-2014 1,044277 0,0129105 446 1,296991 0,0790867 932 
Table 40: Control group employment growth according to year for the pharmaceutical 
and IT-service industries 
For the overall control group the financial crises can be detected and the 
growth rates are exceptionally low, both for the pharmaceutical and IT-service 
industry. The differences in average employment growth rates are especially 
interesting when looking at the overall dataset. A difference of over 13% can 
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be measure at a significance level of just over 5%, when looking at the aver-
age of years 1 to 5 after filing.  
 
Group Overall     Difference Std Error Degrees of F. Pr(T > t) 
    1-5 0,1311154 0,0811213 4.191 0,0531 
    1-10 0,0841387 0,0723133  5.072 0,1223 
    
Group Pharmaceutical IT-Services 
Difference Std Error Degrees of F. Pr(T > t) Difference Std Error Degrees of F. Pr(T > t) 
1-5 0,0437561 0,0589121 1.110 0,2289 0,1293668 0,1104289 3.079 0,1207 
1-10 0,053281 0,0569903 1.297 0,175 0,062887 0,0977883 3.773 0,2601 
Table 41: Differences in employment growth rates 
Another interesting observation is the pharmaceutical industry. Comparing the 
difference in average growth rates of the years 1 to 5 and years 1 to 10 after a 
filing, ones notices that the difference is rising. This is in strong contrast to the 
IT-service industry and an interesting observation even though it is not signifi-
cant.  
Based on the results from the simple comparison of growth rates, a first con-
clusion can be drawn. Looking at the two industries, especially the IT-service 
companies stand out. For them the filing of a trademark has a bigger impact 
and the growth rates are higher compared to the case when no trademark 
was filed. Based on the assumption that growth rates imply differentiation and 
innovation, this implies that trademarks can be used as an indicator of innova-
tion in IT-services, respectively in KIBS.  
Growth Analysis by Trademark Type 
After the general growth analysis, the next part compares different types of 
trademarks and derives conclusions from it. First sales, afterwards employ-
ment rates are computed. 
Sales	  Growth	  
Firstly, the type of trademarks are analysed for the whole dataset. Word 
trademarks are the most used form overall. Comparing the growth figures, 
one directly notices that word trademarks have the highest rates of all type 
with 27% on average. Figurative have the second highest average sales 





Year Mean Std Error Observations 
1-5 1,339262 0,1668019 1351 
6-10 1,087409 0,0185647 486 
1-10 1,272631 0,122786 1.837 
Figurative 
1-5 1,213539 0,0635363 589 
6-10 1,108547 1,108547 313 
1-10 1,177106 0,0430264 902 
Other 
1-5 0,987840 0,0189939 8 
6-10 1,053992 0,0257748 14 
1-10 1,029937 0,0188059 22 
Table 42: Sales growth rates by trademark type for the dataset 
The other types of trademarks experience very little sales growth after filing 
with an average of only 2,99%. Moreover, the filings are very rare with only 22 
observations. 
 
  Pharmaceutical IT-Services 
Word 



















1-10 1,108918 0,0242409 541 1,340972 0,173732 1.296 
Figurative 
1-5 1,066723 0,0133210 219 1,300438 0,1006136 370 
6-10 1,082532 0,0574744 145 1,131001 0,0353364 168 
1-10 1,073020 0,0242133 361 1,247528 0,0701190 538 
Other 
1-5 0,987840 0,0189939 8    
6-10 1,053992 0,0257748 14    
1-10 1,029937 0,0188059 22 - - - 
Table 43: Sales growth rates by trademark type for the pharmaceutical and IT-
service industries 
Differentiating by industries confirms the overall findings. However, the differ-
ences in the pharmaceutical industry are not as strong between word and fig-
urative. An explanation for this phenomenon might be that the combination of 
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word and figurative trademarks is much higher in the pharmaceutical industry 
and hence, the difference in sales growth are smaller.  
Employment	  Growth	  
Performing the same analysis with employment growth results in a different 
outcome. Looking at the complete dataset is becomes clear that the figurative 
trademarks achieve higher growth, but only by 1% and furthermore, with a 
much higher volatility. 
 Overall 
Word 
Year Mean Std Error Observations 
1-5 1,341668 0,0477032 2400 
6-10 1,141244 0,0342244 786 
1-10 1,292223 0,036942 3.186 
Figurative 
1-5 1,337522 0,0962083 1085 
6-10 1,237256 0,1381528 449 
1-10 1,308174 0,0791408 1534 
Other 
1-5 0,997460 0,0347479 13 
6-10 1,015364 0,0126391 21 
1-10 1,008518 0,0151647 34 
Table 44: employment growth rates by trademark type for the dataset 
Other trademarks hardly achieve any growth (0,85%) and are rarely used. 
Separating by industry, word trademarks are more effective for pharmaceuti-
cal companies, while in the IT-service industry figurative trademarks experi-
ence the highest growth. This is an interesting finding, which cannot be con-
firmed by any other results. In comparison to the sales growth rates, both 
word and figurative trademarks achieve higher growth, while in the pharma-
ceutical industry the growth rates are lower.  
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  Pharmaceutical IT-Services 
Word 
Year Mean Std Error Observations Mean Std Error Observations 
1-5 1,094810 0,0532959 591 1,422317 0,0607327 1809 
6-10 1,135349 0,0831874 172 1,142895 0,0371398 614 
1-10 1,103949 0,045321 763 1,351510 0,046371 2.423 
Figurative 
Year Mean Std Error Observations Mean Std Error Observations 
1-5 1,036494 0,0177553 314 1,460120 0,1349734 771 
6-10 1,080222 0,0617300 182 1,344298 0,2284363 267 
1-10 1,052539 0,0252659 496 1,430328 0,116160 1038 
Other 
Year Mean Std Error Observations Mean Std Error Observations 
1-5 0,997460 0,0347479 13    
6-10 1,015364 0,0126391 21    
1-10 1,008518 0,0151647 34  - - - 
Table 45: employment growth rates by trademark type for the pharmaceutical and IT-
service industries 
In general the results show that there are substantial difference between 
trademarks and that these differences can predict innovation in a better or 
worse way. Word and figurative trademarks are suitable indicator of innova-
tion for both industries. While the word trademarks are better applicable in the 
pharmaceutical sector, for IT-service companies the results are mixed and 
decision between the two trademark types cannot be made. Other trademarks 
are unsuitable as an indicator since they are hardly used and do not predict 
any outstanding growth.  
Growth Analysis by Size 
As a next part the possibility to measure innovation through trademarks is ex-
amined in small companies with less than 101 employees. For simplicity rea-
sons, only the average growth rates are considered regarding the trademark 
as well as the control group.  
Sales	  Growth	  
Firstly, a growth analysis by the year since filings is conducted. In comparison 
to the overall dataset the mean growth rates are higher overall and for each 
industry. Furthermore, IT-service companies experience stronger growth in 
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the first five years experience than the second ones. The difference for IT-
services between the first and the last 5 years amounts to almost 40%. 
 
Trademark Group / SMB 
Sales Growth Overall 
year Sales Growth Std Error Observations 
1-5 1,411128 0,2220404 1013 
6-10 1,098385 0,231372 360 
1-10 1,329127 0,163954 1.373 
Table 46: Sales growth according to years after filing of trademark for the all SMBs 
Trademark Group / SMBs 
Sales Growth Pharmaceuticals IT-Services 
year Sales Growth Std Error Observations Sales Growth Std Error Observations 
1-5 1,156964 0,0520477 213 1,474827 0,2773715 810 
6-10 1,186898 0,1130216 64 1,079248 0,0139825 296 
1-10 1,164139 0,047853 267 1,368957 0,203207 1.106 
Table 47: Sales growth according to years after filing of trademark for SBMS phar-
maceutical and IT-service companies 
For the pharmaceutical industry it is the other way round. Like previous re-
sults, the growth rates are stronger within years 6 to 10. Overall the IT-
services industry has higher growth rates compared to the pharmaceutical in-
dustries: however, year 6 – 10 are stronger for pharmaceuticals .  
Next, the growth rates for the control group are computed and then compared 
to the trademark group. While none of the differences are statistically signifi-
cant, implications from the results can be drawn. Firstly, the small pharmaceu-
tical companies have less sales growth compared to the control group. 
 
Control Group / SMB 
   Sales 
Growth Overall 
   
year 
Sales 
Growth Std Error Observations 
   2006-2014 1,269426 0,090218 539 
   Control Group / SMB 
Sales 
Growth Pharmaceutical IT-Services 
year 
Sales 
Growth Std Error Observations 
Sales 
Growth Std Error Observations 
2006-2014 1,307050 0,258969 120 1,258650 0,089481 419 
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Table 48: Control group sales growth according to year for SMB pharmaceutical and 
IT-service companies  
 
 
Group Overall     Difference Std Error Degrees of F. Pr(T > t) 
    1-5 0,1417029 0,3114718 1.550 0,3246 
    1-10 0,059702 0 1.910 0,4118 
    
Group Pharmaceutical IT-Services 
Difference Std Error Degrees of F. Pr(T > t) Difference Std Error Degrees of F. Pr(T > t) 
1-5 -0,1500862 0,210113 321 0,2378 0,2161764 3910573 1.227 0,2903 
1-10 -0,142911 0,1874779 385 0,2232 0,110307 0,3347729 1.523 0,3709 
Table 49: Differences in sales growth rates for SMBs 
For the small IT-service companies the contrary is true and in the first five 
years after filing they experience over 20% more growth than small compa-
nies that do not file a trademark. These results confirm the previous results 
from the general growth analysis and that trademark filings also result in 
strong growth for small IT-services. For small pharmaceutical companies on 
the other hand the relation between trademarks and growth cannot be proven.  
Employment	  Growth	  
The following part is devoted to the growth analysis of small companies. Simi-
lar to the results for sales growth, the average rate is higher by 3% compared 
to the whole trademark group; however, the standard error stays almost the 
same. Compared to the sales results for the SMBs the average rates are al-
most the same with differences smaller than 1%. 
 
Trademark Group / SMB 
Emp Growth Overall 
year Sales Growth Std Error Observations 
1-5 1,375971 0,0459721 2029 
6-10 1,173338 0,048515 623 
1-10 1,328369 0,0370064 2652 




Trademark Group / SMB 
Emp Growth Pharmaceutical IT-Services 
year Emp Growth Std Error Observations Emp Growth Std Error Observations 
1-5 1,134967 .089968 349 1,426037 .0522096 1680 
6-10 1,205989 .1336871 104 1,166795 .0517687 519 
1-10 1,151272 .0757503 453 1,364852 .0417774 2199 
Table 51: employment growth according to years after filing of trademark for SMB 
pharmaceutical and IT-service companies 
The same applies to the separate industries. The sales results are confirmed 
by the employment analysis meaning that the first 5 years experience higher 
growth than the last 5 in the IT-service sector; again the contrary is true for 
pharmaceutical companies. Comparing the average growth rates of the 
trademark group with the results for SMBs of the control show that most of the 
figures are in the line with the SMBs sales results. Nevertheless, two interest-
ing results come to light. 
 
Control Group / SMB 
   Emp Growth Overall 
   year Emp Growth Std Error Observations 
   2006-2014 1,229713 0,054967 984 
   Control Group / SMB 
Emp Growth Pharmaceutical IT-Services 
year Emp Growth Std Error Observations Emp Growth Std Error Observations 
2006-2014 1,036841 0,020228 247 1,294352 0,072934 737 
Table 52: Control group employment growth according to year for the pharmaceutical 
and IT-service industries  
Group 
Overall / SMB 
    Difference Std Error Degrees of F Pr(T > t) 
    1-5   0,1462585 0,0763111 3.011 0,0277 
    1-10 0,098657 0,0693691 3.634 0,0775 
    
Group 
Pharmaceutical / SMB IT-Services / SMB 
Difference Std Error Degrees of F Pr(T > t) Difference Std Error Degrees of F Pr(T > t) 
1-5  0,0981264 0,1083134 594 0,1827 0,1316846 0,0924518 2.415 0,0772 
1-10 0,114432 0,1036987 698 0,1351 0,070499 0,0836086 2.934 0,1996 
 Table 53: Differences in employment growth rates for SMB 
Firstly, the difference in averages between the control group for the overall 
dataset as well as IT-service sector group for the years 1 to 5 years are both 
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significant at a 5%, respectively, 10% level. Secondly, the difference for the 
pharmaceutical industry is positive, which was not the case for the sale 
growth rates. Interestingly, sales growth is higher for the control group while 
employment growth is higher for the trademark group within SMBs of the 
pharmaceutical industry.  
In summary, trademarks seem to be a good indicator for innovation in small 
companies, especially when looking at the IT-service industry, where the re-
sults are conclusive and pointing towards good usability. However, results for 
pharmaceutical SMBs are inconclusive. While sales growth does not and em-
ployment growth supports the usability of trademarks.  
Growth Analysis by Age 
After examining SMBs, the next step is to have a closer look at different age 
groups of companies and how age affects growth rates and the possibility to 
use trademarks as an indicator of such. For the age analysis the two groups 
defined in the descriptive analysis are combined and young companies are 
classified between the age of zero to ten years.  
Sales	  Growth	  	  
Looking at the sales growth rates an interesting picture is revealed. Firstly, the 
growth rates are high, but not as high as the ones of the complete dataset and 
secondly, the difference between the two industries becomes smaller. While 
the average rate of pharmaceutical companies rises by 3%, the one of IT-
services decreases by almost 5%. Thirdly, the growth rates from year 1 to 5 
are for the first time higher than year 6 to 10 for the pharmaceutical company.  
  Overall 
year Sales Growth Std Error Observations 
1-5 1,277746 0,0433564 630 
5-6 1,126403 0,0291165 190 
1-10 1,242678 0,034051 820 






  Pharmaceutical IT-Services 
year Sales Growth Std Error Observations Sales Growth Std Error Observations 
1-5 1,139675 0,0708832 88 1,300163 0,0490159 542 
5-6 1,098222 0,0656523 25 1,130673 0,0320721 165 
1-10 1,130504 0,056977 113 1,260607 0,038398 707 
Table 55: sales growth according to years after filing of trademark for young from the 
pharmaceutical and IT-service industry 
Fourthly, the growth rates of the control group are strictly higher than the 
trademark group, overall and for both industries. These results are in strong 
contrast to the growth rates results when not differentiating by age.  
 
Control Group / young  
   Sales Growth Overall 
   
year 
Sales 
Growth Std Error Observations 
   2006-2014 1,354977 0,119671 304 
   Control Group / SMB 
Sales Growth Pharmaceutical IT-Services 
year 
Sales 
Growth Std Error Observations 
Sales 
Growth Std Error Observations 
2006-2014 1,189050 0,083956 34 1,375872 0,134310 270 
Table 56: Control group sales growth according to year for young companies from 
the pharmaceutical and IT-service industry  
Group Overall / young     Difference Std Error Degrees of F Pr(T > t) 
    1-5 -0,3499218 0,2385473 371 0,0716 
    1-10 -0,383118 0,2252352 404 0,0449 
    
Group Pharmaceutical / young IT-Services / young 
Difference Std Error Degrees of F Pr(T > t) Difference Std Error Degrees of F Pr(T > t) 
1-5 -0,2591365 0,36447 45 0,2404 -0,3347373 0,2646161 324 0,1034 
1-10 -0,261014 0,3553823 47 0,2332 -0,375783 0,2484393 355 0,0656 
Table 57: Differences in sales growth rates for young companies  
Hereby, all differences in growth rates are significant at least at a 10% level, 
except year 1 to 5 of the IT-service sector, even though the difference is high 
with over 33%. However, it is important to notice that the standard error of the 
young company control group is very high and higher than the young compa-
nies of the trademark group. This can be interpreted as a stabilizing effect of  




The employment growth rates of young companies contrast the sales growth 
in a strong way. The average growth rates of employment are much higher 
than sales. For pharmaceutical companies, the first years have relatively low 
growth and acceleration takes place in the last year, while the opposite is true 
for IT-service companies, thereby confirming the results derived form the 
complete dataset.  
 
  Overall 
year Sales Growth Std Error Observations 
1-5 1,589853 0,0984407 1,351 
5-6 1,291968 0,0987722 304 
1-10 1,535136 0,082419 1.655 
Table 58: employment growth according to years after filing of trademark for young 
companies 
  Pharmaceutical IT-Services 
year Sales Growth Std Error Observations Sales Growth Std Error Observations 
1-5 1,081321 0,0295787 136 1,646775 0,1092931 1215 
5-6 1,614388 0,4034079 29 1,257967 0,1006393 275 
1-10 1,175011 0,075683 165 1,575015 0,091108 1.490 
Table 59: employment growth according to years after filing of trademark for young 
companies from the pharmaceutical and IT-service industry 
The standard error is relatively high for both groups, trademark and control, 
which makes sense regarding the high-risk nature of young companies.  
Control Group / young  
   Emp Growth Overall 
   year Emp Growth Std Error Observations 
   2006-2014 1,359146 0,093684 569 
   Control Group / SMB 
Emp Growth Pharmaceutical IT-Services 
year Emp Growth Std Error Observations Emp Growth Std Error Observations 
2006-2014 1,095361 0,043049 87 1,406758 0,110201 482 
Table 60: Control group employment growth according to year for young companies 





Group Overall / young     Difference Std Error Degrees of F Pr(T > t) 
    1-5 0,2307077 0,1634303 1.918 0,0791 
    1-10 0,175990 0,1509263 2.222 0,1219 
    
Group Pharmaceutical / young IT-Services / young 
Difference Std Error Degrees of F Pr(T > t) Difference Std Error Degrees of F Pr(T > t) 
1-5 -0,0140403 0,0505212 221 0,6093 0,2400172 0,1869074 1.695 0,0996 
1-10 0,079650 0,1088925 250 0,2326 0,168257 0,1682574 1.970 0,1641 
Table 61: Differences in employment growth rates for young companies  
The differences are normally positive, indicating bigger rates by young com-
panies from the trademark group. Nevertheless growth rates of control phar-
maceutical companies are higher by 1% in the first five years after filing a 
trademark, but this changes in when looking at the whole 10 years. Significant 
differences are the 1 to 5 years after for the overall group and the IT-services. 
Summing up the results of the young company analysis, a contradictory pic-
ture was formed. On the one hand, sales figures do not indicate any useful-
ness of trademarks as an indicator since the control group achieves higher 
growth compared to the trademark group. One the other hand the employ-
ment results indicate such usefulness as and indicator because the results 
are the other way round. A potential explanation for the different in results for 
pharmaceuticals and IT-services is the nature of young companies and the 
meaning of growth in sales versus employment. Young companies operate in 
a high-risk environment and sales growth is especially volatile. While good 
performance and strong growth is captured by the company information, weak 
sales growth in case of bankruptcy is not captured since no further sales in-
formation are provided on which basis growth calculations could be made. 
This explanation is supported by the findings from the descriptive analysis re-
garding the sales per trademark. The volatility is especially high for compa-
nies with few trademarks. Employment growth for young companies on the 
other hand is more stable and does not adopt as quickly as sales growth. The 
results implies that trademarks might be an indicator of innovation for young 
companies; however, further research in this area has to be conducted and 
possible adjustments for young companies tested.  
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Growth Analysis of Trademarks and Patents 
Lastly the influence of combined usage of different IPRs will be examined for 
the dataset. Hereby, three different groups will be distinguished: 1) companies 
with trademarks and patents 2) companies with trademarks only 3) companies 
with patents only. The results are discussed in the following part. 
Sales	  growth	  
Firstly, an overview over the whole dataset is given in table 62.  Comparing 
the different groups shows that the group with companies that which only 
have trademarks is the biggest, while the groups with only patents and trade-
marks and patents have a similar number companies. Interestingly, the group 
of companies that combine trademarks and patents have the lowest growth 
rates on average and the companies, which only have trademarks experience 
the strongest growth with more than 5% difference. 
 
Sales growth Overall 
Group year Sales Growth Std Error Observations 
Trademark 
& Patent 
1-5 1,117102 0,0248586 431 
5-6 1,127318 0,0575061 140 
1-10 1,119607 0,023444 571 
Only 
Trademark 
1-5 1,387604 0,2036937 1.105 
5-6 1,083863 0,0142643 419 
1-10 1,304095 0,147766 1.524 
Only Patent 2006-2014 1,251057 0,082292 654 
Table 62: Comparison of sales growth by patent and trademark groups 
Sales growth Pharmaceutical IT-Services 
Group year Sales Growth Std Error Observations Sales Growth Std Error Observations 
Trademark 
& Patent 
1-5 1,107672 0,0324645 270 1,132916 0,0383635 161 
5-6 1,171579 0,1087579 72 1,080454 0,0280972 68 
1-10 1,121126 0,034305 342 1,117338 0,028241 229 
Only 
Trademark 
1-5 1,104897 0,0349318 188 1,445564 0,2453291 917 
5-6 1,042300 0,0306887 58 1,090540 0,0157910 361 
1-10 1,090138 0,027682 246 1,345279 0,176116 1.278 
Only patent 2006-2014 1,168536 0,134077 232 1,296424 0,104125 422 
Table 63: Comparison of sales growth by patent and trademark groups for the phar-
maceutical and IT-service industries 
The assessment by industry reveals further interesting insights. The strongest 
growth in the pharmaceutical industry is achieved by companies, which only 
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have patents. In contrast IT-service companies with only have trademarks 
have the highest growth rates, almost twice as much as any pharmaceutical 
group.  
 
Group Overall Sales 
Only Trademarks versus Only Patents Difference Std Error Degrees of F Pr(T > t) 
1-10 0,053038 0,2319453 2.176 0,4096 
Group Pharmaceutical IT-Services 
Difference Std Error Degrees of F Pr(T > t) Difference Std Error Degrees of F Pr(T > t) 
1-10 -0,078398 0,1332824 476 0,2783 0,048855 0,3123233 1.698 0,4379 
Table 64: Comparison of difference in sales growth for only patent and only trade-
mark group 
While no differences are significant, table 64 provides interesting insights 
about the impact of IPRs on sales growth. While patents seems to be the bet-
ter indicator for pharmaceutical, IT-service companies rely more on trade-
marks and its usage better illustrates innovation reflected through growth.  
Employment	  growth	  
Similar to the sales growth results, the combined trademark and patent group 
experiences the smallest growth among the three and the group with compa-
nies which only use trademarks the strongest.  
Sales growth Overall 
Group year Emp Growth Std Error Observations 
Trademark 
& Patent 
1-5 1,152508 0,0568324 652 
5-6 1,091559 0,0462146 204 
1-10 1,137983 0,044663 856 
Only 
Trademark 
1-5 1,404733 0,0631216 2.163 
5-6 1,166615 0,0465637 677 
1-10 1,347970 0,049372 2.840 
Only patent 2006-2014 1,175110 0,054548 1.101 
Table 65: Comparison of employment growth by patent and trademark groups  
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Sales growth Pharmaceutical IT-Services 
Group year Emp Growth Std Error Observations Emp Growth Std Error Observations 
Trademark 
& Patent 
1-5 1,025926 0,0113086 373 1,321737 0,1314025 279 
5-6 1,056155 0,0521523 97 1,123654 0,0744628 107 
1-10 1,032165 0,013990 470 1,266828 0,097239 386 
Only 
Trademark 
1-5 1,167098 0,1067498 293 1,441967 0,0710400 1870 
5-6 1,212662 0,1490379 90 1,159555 0,0486495 587 
1-10 1,177805 0,088774 383 1,374496 0,055351 2.457 
Only patent 2006-2014 1,045688 0,014495 368 1,240085 0,081523 733 
Table 66: Comparison of employment growth by patent and trademark groups for the 
pharmaceutical and IT-service industries 
Examining the groups separately by industry, some differences are revealed. 
Firstly, the highest growth among the different groups is for both industries 
achieved by the groups of companies that only use trademarks. The second 
highest growth rates varies by industries. While the differences are quite low, 
the combined usage of trademark and patents performed better in the IT-
service industry and than the sole usage of patents, it is the other way round 
in the pharmaceutical industry. 
 
Group Overall Employment 
Only Trademarks versus Only Patents Difference Std Error Degrees of F Pr(T > t) 
1-10 0,172861 0,0862658 3.939 0,0226 
Group Pharmaceutical IT-Services 
Difference Std Error Degrees of F Pr(T > t) Difference Std Error Degrees of F Pr(T > t) 
1-10 0,132117 0,0916755 749 0,0750 0,134411 0,1106944 3.188 0,1124 
Table 67: Comparison of difference in sales growth for only patent and only trade-
mark group 
In contrast to the sales growth, the differences between isolated usage of pa-
tents and trademarks significant for the industries combined as well as the 
pharmaceutical industry.  
In conclusion, the results for the pharmaceutical industry are inconclusive for 
the combined data of patents and trademarks. While patents better indicate 
innovation through sales growth, trademarks are superior regarding employ-
ment information. However, the usage of trademarks as an indicator of inno-
vation seems highly effective for IT-service companies confirmed by sales as 
well as employment. Interestingly, the combination of patents and trademarks 
in neither industry is a good indicator of potential growth.  
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Conclusion  
The aim of this study was to examine the usefulness of trademarks as a com-
plementary indicator of innovation based on evidence from the German phar-
maceutical and IT-service industries. In order to test the potential application 
of trademarks as an indicator, a new approach was developed. Instead of re-
lying purely on the correlation between patents and trademarks, growth anal-
yses were conducted based on sales and employment. The rational is that the 
majority of new trademarks are only registered if they are linked to an innova-
tion new to the company and that this innovation can be measured in sales 
and employment growth (Mendonça, Pereira, and Godinho, 2004). Further-
more, a special attention was given to KIBS. KIBS industries were adversely 
affected by previous indicators of innovation because they make little R&D 
investments and hold patents. Thus, using trademarks is a way to better un-
derstand innovativeness within such companies.   
The results found in this study support the usage of trademarks as an indica-
tor of innovation with limitations. The descriptive analysis shows that a strong 
correlation between patents and trademarks can be found for the pharmaceu-
tical industry indicating a connection between innovation and trademarks. 
Employment growth confirms the connection between trademarks and innova-
tion and finds that pharmaceutical companies of the trademark group achieve 
higher employment growth compared to the control group. However, these 
results cannot be confirmed by the sales growth analysis, where the control 
group achieves significantly higher growth rates.  
In contrast to the findings for the pharmaceutical industry are the results of the 
IT-service industry. While no correlation between patents and trademarks can 
be found, these IT-service companies rely relatively stronger on trademarks, 
which is potentially a result of their nature as a service business. Furthermore, 
the growth rates for sales and employment confirm the thesis that trademarks 
are filled for products with a major differentiation compared to the market. In 
both cases the trademark group experiences higher growth rates and espe-
cially in the first five years the difference to the control group is substantial.    
A classification of trademarks shows that 3D, colour and sound trademarks do 
not provide insights about growth. Only world and figurative ones have an im-
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pact on growth and indicate a connection to innovation. However, it becomes 
clear that there are substantial differences in trademarks and that these dif-
ferences could provide further insights. 
The refined analyses for size and age paint an inconclusive picture. The re-
sults for small companies confirm the findings of the general growth analyses 
and determine the usefulness of trademarks as an indicator for innovation in 
small IT-service companies, the findings for small pharmaceutical companies 
are mixed. While employment growth confirms the connection to innovation, 
sales growth shows gives negative results. Regarding the age analysis, not 
connection between sales growth and trademarks can be proven for pharma-
ceutical as well as IT-service companies. A potential explanation for these 
findings is the high-risk nature of young companies and that only the positive 
growth cases are captured. The high volatility and employment growth sup-
port this explanation. Trademarks reduce the fluctuation in sales growth for 
young companies and the more stable and long-term oriented employment 
growth hast higher rates compared to the control group. Nevertheless, further 
studies about the impact of trademarks on small companies should be con-
ducted in order to get a better understanding.  
As a last part the combined influence of patents and trademarks on growth 
was examined. The results show that pharmaceutical companies, which hold 
patents, experience the strongest growth. The contrary is true for the IT-
service industry. Here companies, which only have trademarks, experience 
the highest growth. This is confirmed by the employment growth statistics.  
The overall results demonstrate the superiority of trademarks as an indicator 
of innovation compared to patents for the IT-service industry. Sales as well as 
employment growth are higher after the filing of a trademark and the results 
are in line with previous findings for KIBS (Gotsch and Hipp, 2012; Hipp and 
Grupp, 2005; Schmoch and Gauch, 2009). Ambiguous results are only found 
for young companies.  
Regarding the pharmaceutical industry, a differentiation between sales and 
employment growth has to be made. While sales growth does not confirm the 
usefulness of trademarks, the opposite is true for employment. A potential ex-
planation for this might be the long development times of pharmaceutical 
products and hence the longer planning horizon in the pharmaceutical indus-
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try. Evidence for this are the sales growth rates, which accelerate in the years 
6 to 10. Also the results for employment growth support the explanation since 
employment is a more long-term oriented figure.  
In general the usefulness of trademarks as an innovation indicator can be 
confirmed and the findings are in line with previous studies (Malmberg, 2005; 
Mendonça, Pereira, and Godinho, 2004; Millot, 2009). Nevertheless, differen-
tiations have to be made regarding the application of different industries or the 
age of companies.  
Future	  Research	  
This study of trademarks as an indicator of innovation provides interesting re-
sults; however, it has several limitations and produces some inconclusive out-
comes. Firstly, an examination of the timing of the filing of trademarks within 
the pharmaceutical industry may refine the results of this study. There are ev-
idence that sales growth rates pick up at a later stage, which can be used to 
examine the connection between trademarks and sales growth.  
Furthermore, the evidences for young companies are ambiguous and more in 
depth analysis for these companies would help to gain a better understanding 
of the influence of trademarks. Especially sales growth is a flawed indicator 
for young companies since only the positive variation in is captured and the 
case of bankruptcy not covered. An analysis of survival rates might help to 
gain better insights into a potential connection with trademarks and innova-
tion.  
Furthermore, a more refined classification of trademarks might provide further 
insights as can be deduced from the type analysis of trademarks. One possi-
ble differentiation could be along brand identification and brand association 
trademarks as proposed by Krasnikov, Mishra and Orozco, (2009). Also the 
classification of a trademark according to its value might provide a better un-
derstanding. A proxy to determine the value could be the number of opposi-
tions of a trademark. 
Lastly, the connection between filled trademarks and the share of revenue 




Appendix	  1:	  Companies	  with	  patents	  by	  industry	  and	  group	  







Pharmaceutical 146 17714 
IT services 130 596 
Overall 276 18310 
Control 
Group 
Pharmaceutical 126 4065 
IT services 218 467 
Overall 344 4532 
	  

















































Appendix	  5:	  Overall	  trademark	  distribution	  by	  age	  
Year 2014 Overall 
Age Cluster Trademarks Std. Error Observations 
0 1,3 0,097353 50 
1 1,4 0,092919 166 
2 1,6 0,117100 169 
3 1,9 0,285974 105 
4 3,1 1,064289 68 
5 1,7 0,169443 61 
6-10 2,3 0,205907 266 
10-15 2,8 0,223441 305 
15-25 4,9 1,806216 258 
25-50 6,0 1,298655 116 
50-100 15,7 6,093102 60 
>100 47,7 1,845067 27 
Mean Age 14,56 
Skewness 5,72 
Kurtosis  39,04 
 
Appendix	  6:	  Overview	  Sales	  cluster	  
Sales 
[in 000 €] 
Overall Pharmaceutical IT Services 
# % # % # % 
< 500 197 19,6% 14 6,3% 183 23,3% 
[500 - 1.000[ 116 11,5% 16 7,1% 100 12,7% 
[1.000 - 5.000[ 350 34,8% 48 21,4% 302 38,4% 
[5.000 - 10.000[ 123 12,2% 29 12,9% 94 12,0% 
[10.000 - 100.000[ 168 16,7% 68 30,4% 100 12,7% 
[100.000 - 1.000.000[ 36 3,6% 31 13,8% 5 0,6% 
[1.000.000 - 10.000.000[ 14 1,4% 15 6,7% 2 0,3% 
> 10.000.000 3 0,3% 3 1,3% 0 0,0% 
- 660   71   589   
Total 1.667 100% 295 100% 1.375 100% 
Mean Sales 125.795 530.455 12.017 
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Appendix	  7:	  Employment	  distribution	  
Emp Overall Pharmaceutical IT Services 
# % # % # % 
1 238 14,3% 23 7,9% 215 15,6% 
2 187 11,2% 14 4,8% 173 12,6% 
3 -5 173 10,4% 19 6,5% 154 11,2% 
6-10 164 9,8% 18 6,2% 146 10,6% 
11-50 488 29,3% 81 27,7% 407 29,6% 
51-100 140 8,4% 29 9,9% 111 8,1% 
101-1000 172 10,3% 76 26,0% 96 7,0% 
>= 1001 30 1,8% 26 8,9% 4 0,3% 
- 75 4,5% 6 2,1% 69 5,0% 
Total 1.667 100% 292 100% 1.375 100% 
Mean 236 1.131 40 
 
Appendix	  8:	  Linear	   regression	  of	  employment	  per	   trademark	  by	  trademark	  group	  
for	  the	  overall	  dataset	  and	  by	  industry	  
Overall 
    emp_ntrade Coef. Std. Err. P>t 
    ntrade 0,25 0,1398 0,072 
    _cons 29,43 2,9648 0,000 
    
        Number obs 1.592 
      R-squared 0,0020 
      
        Pharmaceutical IT-Service 
emp Coef. Std. Err. P>t emp Coef. Std. Err. P>t 
ntrade 0,09 0,2636 0,730 ntrade -0,66 0,6283 0,294 
_cons 68,69 12,9783 0,000 _cons 23,29 2,5869 0,000 
        Number obs 286 
  
Number obs 1.306 
  R-squared 0,0004 
  
R-squared 0,0008 
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